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Preface
I am a tool builder and optimizer, and at times a decent theorist, 
if I can muster the attention. I enjoy understanding a problem, and 
determining efficient solutions. I honestly believe that most scientific 
work is a series of failures that results in something worth writing 
about. My favorite quote from a peer, David J States, describes 
complex projects, “Fail early and often, or late and spectacular.” This 
quote reminds me that most problems can be solved by repeated small 
failures, and I like to think that I'm pretty good at that. I hope to keep 
avoiding the spectacular failures throughout life. So far so good. 
Proteomics poses many complex problems. The field itself relies greatly 
on Bioinformatics, which itself is still quite a novel term to most and 
certainly a young field. An appropriate one-line summary is the 
following. I understand how to and can collect my own data but 
primarily my job is to develop algorithms and use statistics to 
determine what can be learned from huge amounts of proteomics data. 
Certainly a few great software tools exist for proteomics and almost 
every other year a significant advancement occurs in the 
instrumentation, which dramatically changes the amount, quality, and 
type of data generated. Early on in my career I realized this critical 
point. Proteomics, science in general too, is an appreciation of how 
much we don't yet know. The best that can be done is to narrow the 
scope to a tangible problem and to move it forward. Repeat the 
process a few times and you have a thesis.
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The specific proteomics problem I elected to work on is that of 
inferring peptide and protein sequences from mass spectrometry data. 
My efforts are described in considerable detail throughout this 
manuscript. I feel it is important to note that I have also spent a lot of 
effort and time enabling others to repeat what I've done and apply my 
algorithms and software tools to their proteomics problems. Never did I 
entertain the thought of my work completely solving all the problems 
of proteomics. Rather, I hoped to make several significant 
advancements, and greatly accelerate similar research. I feel I have 
been successful in my efforts, and in particular I have high confidence 
in many components of my work, particularly Tranche and Bonanza. 
These latter projects are now being used by a large number of 
proteomics researchers. In particular, I am quite pleased that all of my 
work is available as both free and open-source, largely thanks to 
shared philosophies with Phil Andrews and public accessibility efforts 
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Mass spectrometry is formally defined as an analytical technique 
that measures of the mass to charge ratio of ions. Typically a collection 
of ions are analyzed simultaneously and the mass spectrometer 
generates a mass spectrum (MS) that can be used to interpret the 
mass to charge ratio of ion species present in detectable quantities. 
Modern mass spectrometers are largely based off of designs by A.J. 
Dempster and F.W. Aston, developed in 1918 and 1919 respectively. 
Aston later received the Nobel Prize in Chemistry for his work in mass 
spectrometry in 1922. However, much more recent developments in 
mass spectrometry have made the technique viable for analyzing ions 
that were previous difficult to desorb or ionize. In 1987 both 
electrospray ionization (ESI)[1] and soft laser desorption (SLD)[2], 
developed by John B. Fenn et al. and Koichi Tanaka et al. respectively, 
and matrix assisted laser desorption/ionization (MALDI)[3], developed 
by Franz Hillenkamp et and Michael Karas, were developed. In 2002 
John B. Fenn and Koichi Tanaka were awarded the Nobel Prize in 
Chemistry for developments in mass spectrometry[4], albeit with a 
lack of award to Michael Karas and Franz Hillenkamp. Both ESI and 
MALDI are now in widespread use and allow for the analysis of peptides 
and proteins and their complexes via mass spectrometry. While mass 
spectrometry-based protein analysis is not the only tool used in 
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 proteomics, without the ESI and MALDI ionization method the work 
presented in this thesis would not be possible.
The Nobel Prize awarded in 2002 to Fenn and Tanka reflects that 
their work enabled a key part of proteomics, the ionization of intact 
peptides and proteins without the use of chemical modifications to 
enhance volatility. Once successfully ionized, the masses of these 
molecules could accurately be measured, which enabled a wealth of 
new knowledge to be collected on biological samples. Further 
developments in mass spectrometers and software would enable 
complex protein samples, such as tissue or serum, to be analyzed in 
high-throughput experiments and for one of the first times it is possible 
to attempt to survey the state of many, and potentially all, proteins in 
a living organism. The full potential of this development has yet to be 
realized, but certainly many notable experiments have been 
performed. One of the most influential strategies of protein analysis via 
mass spectrometry was describe by Eng et al. [5]. Eng describes the 
process of a shotgun proteomics experiment a statistical correlation of 
peptide identifications to mass spectrometry data and subsequent 
inference of protein identifications. In short, many proteins are too 
large to be ionized well for mass spectrometry and many mixtures are 
too complex to be analyzed alone. Shotgun proteomics relies on 
converting a complex mixture of protein into a set of smaller peptides 
that are applicable for mass spectrometry, those peptides are then 
automatically separated based on intrinsic properties, and finally mass 
spectrometry is used to analyze the entire sample. Post data collection, 
the resulting mass spectra are compared against a library of known 
protein sequences. A statistical analysis is then used to infer the 
original set of proteins analyzed. Shotgun proteomics is often done 
with a similar set of conditions for creating peptides, separating, 
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analyzing, and finally inferring protein identifications; however, each of 
the particular components can be altered and various forms of such 
alteration comprise a large portion of current proteomics literature [6, 
7, 8]. 
Most all of the proteomics work described in this manuscript is 
predicated on developments and refinements of the initial shotgun 
proteomics strategy. Good reviews exist [9] including comprehensive 
terminology standards [10], but it is relevant to review this information 
in order to frame the rest of the manuscript coherently. Figure: 1-1 
provides a conceptual overview of shotgun proteomics and also 
includes a brief cartoon that illustrates the protein chemistry of 
interest. Peptide and protein chemistry itself is a complete discipline; 
however, for the purposes of this manuscript, it largely suffices to 
present proteins as nothing more than a long string of English alphabet 
characters. In this context, Peptides are simply shorter strings of the 
same characters. The sequence (not active structure) of proteins can 
be reasonably well represented by such strings because each protein is 
primarily comprised of combinations of the standard 20 amino acids. 
Modifications of these 20 amino acids do occur in proteins but 
discussion of relevant ones will largely be left undiscussed until 
chapter 6. Figure 1-1 continues the proteins as strings analogy to 
describe mass spectrometry based proteomics.
Figure 1-1b illustrates the effect of proteolytic digestion of a 
protein, or splitting the string in context of the textual analogy 
mentioned above. Different mass spectrometers are capable of 
measuring a broad range of mass to charge ratios at various 
sensitives; however, generally, mass spectrometers target ions with a 
m/z between the range of 200-3,000 Da when applied to shotgun 
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proteomics. The majority of data analyzed in this manuscript is 
generated by a mass spectrometer optimized to analyze m/z of 
900-2,500 Da. Phrased differently, strings of approximately 6 to 25 
characters. Known protein sequences range anywhere from a few 
characters to thousands, often with more than a few hundred 
characters per protein. Thus, the process of proteolysis is critical in 
order to convert proteins into peptides that are compatible for mass 
spectrometry analysis. Trypsin in particular is popular because it tends 
to work predictably, results in many peptides of the desired size, and 
finally tends to leave each peptide with a single positively charged 
amino acid at the C-terminus.
Figure 1-1c illustrates what will be presented in this manuscript 
as a primarily black-box process of mass spectrometry.  Peptides are 
ionized and analyzed by the mass spectrometer and resulting spectra 
are generated. For the purpose of the work described in this 
manuscript, attention must be focused on the meaning of the mass 
spectra; however, the inner-workings of the physical mass 
spectrometer are relevant in the sensitivity and resolution of the mass 
spectra. Several excellent reviews for commonly used mass 
spectrometers exist, and discussion of particular relevant features will 
not occur until chapter 6. Figure 1-2 clarifies the precise data of 
interest in this manuscript, a mass spectrum, which is also represented 
in Figure 1-1c. Resulting spectra have several properties of interest. 
Depending on the mass spectrometer, spectra will represent different 
features – e.g. mass defect, mass limit, and mass range – have 
different mass resolution and mass resolving power for determination 
of isotopic states. Each of these aspects generally contributes 
significantly to the confidence of identifications inferred by software 
developed for protein and peptide identification. In order to infer 
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peptides represented by a mass spectrum, each m/z must be 
compared to a set of known existing peptide masses. Such a list can 
easily be obtained by processing an existing list of possible protein 
sequences to obtain a set of all theoretical peptides. Many appropriate 
publicly accessible protein databases exist, including the RefSeq 
databases from the National Center for Biotechnology Information 
(NCBI) [11] and the European Bioinformatics Institute's (EBI) 
International Protein Index (IPI) [12]. A complete list and archive of 
current and previous versions of these protein databases is available 
from the ProteomeCommons.org/Tranche FASTA resource [13]. 
Assuming one has an appropriate list of theoretical peptides and a 
mass spectrum, inference of peptides present in the spectra can be 
accomplished by creating a sublist of theoretical peptides that would 
have the same m/z as ions present in the mass spectra. This list can 
further be reduced by filtering out peptides that should not be present 
according to experimental steps taken prior to peptide ionization. 
Generally, even the most minimal lists of theoretical peptides for a 
shotgun proteomics experiment can result in ambiguous matches to 
observed m/z in a mass spectrum. Several statistical approaches have 
been developed to address this [14, 15]. In short, algorithms rely on 
the mass accuracy of the MS instrument to reduce the potential 
peptides matches for any observed MS peak. This practice is then 
combined with a statistical estimation of how likely a random protein 
will have a peptide that matches an observed peak. The results can 
often yield a confident identification for samples with low complexity; 
however, tandem mass spectrometry (MS/MS) is typically employed as 
an orthogonal approach to identify present peptides with high 
confidence in samples of higher complexity. If an instrument is MS/MS 
capable, typically MS analysis is completely ignored in favor of the 
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information rich MS/MS. Figure 1-2 illustrates an example MS/MS 
spectrum. The data are similar to that of a MS spectrum, but instead of 
looking at multiple peptides simultaneously, a single peptide is isolated 
from the MS scan, fragmented, and re-analyzed by itself. The resulting 
MS/MS spectrum represents a ladder of masses that can be matched 
back to the theoretical amino acid sequence of the source peptide. 
Thus, for a shotgun proteomics, a logical way to infer peptides from a 
complex mixture is to separate them as best as possible prior to 
ionization for MS, repeatedly select different MS ions for MS/MS, and 
finally create a software package that can efficiently process all 
spectra and match appropriate theoretical peptide sequences (Figure 
1-1d). If the results are taken one step further, as shown in Figure 1-1e 
the set of identified peptide sequences can be used to identity what 
source proteins were likely present.
Current software trends in the field of mass spectrometry-based 
proteomics can be well described by the final step illustrated by Figure 
1-1 (c) and (d). Tandem mass spectra represent a wealth of information 
that can be valuable for understanding a number of biological and 
physical processes. Exactly how peptides fragment and form MS/MS is 
not completely understood and is itself an active area of research 
[16-18]. Significantly different fragmentation can be observed 
depending on properties of the peptide, amount and frequency of 
applied excitation energy, and characteristics of different mass 
spectrometers. Due in part to the incompletely understood 
fragmentation mechanisms, it should be no surprise that another 
active area of research is that of refining software algorithms to 
correctly infer peptide identifications based on MS/MS data [19-30]. It 
is fair to state that the peptide inference problem itself is the most 
active area of current research. Many groups are working on logical 
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refinements to existing search algorithms in order to improve the 
statistics, selectively identify particular post translational 
modifications, or simply speed up performance. Post MS/MS analysis 
represents the next, currently popular area of algorithm development. 
Many researchers are working on creating better software for inferring 
protein identifications based on sets of inferred peptides [31-33]. A 
naive approach of identifying all proteins that share an observed 
peptide will excessively identify proteins. Many proteins share the 
same peptides, and effort must be placed in identifying what protein 
most likely is represented given all observed peptide identifications. 
This is particularly important when dealing with homologous proteins 
that share large portions of sequence. Protein inference algorithms 
must carefully identify what homologous proteins are clearly present 
versus ambiguously identifiable proteins. Additionally, several areas of 
research distinct from the original MudPIT analysis pipeline have also 
emerged. Protein database independent identification of peptide 
sequences based solely on MS/MS data is quickly becoming a viable 
alternative to database techniques. This practice is often referred to as 
de novo peptide sequencing [34]. The de novo algorithms have had 
limited widespread adoption, but share a significant portion of active 
research interest. Also, libraries of known peptide identifications and 
mass spectra have started to emerge [35-37]. The practice is based 
around the concept that existing MS/MS based peptide identifications 
can be recycled. A statistically valid identification should generally hold 
true across data sets, and valuable time and identifications can be 
inferred from old data to new. Such libraries are becoming popular now 
because of the increasing availability of data sets, in a large part due 
to Tranche. Comparison to both a known library of identifications and a 
theoretical set of proteins is a promising standard for future MS/MS 
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analysis. It is both a very logical direction and becoming much more 
practical due to open-access, large-scale data set publication. Finally, 
several resources have emerged to help aggregate mass spectrometry 
based information [38-41]. This thesis work describes one of the most 
prominent, Tranche, which has established a P2P network for scientific 
data sharing. A core set of computers supported by various groups and 
organizations maintains the majority of data on the network; however, 
individual users computers are also used to help host data, increase 
the availability of on-line data, and speed up downloads.
Critique of Existing Methodology
Reinvention of the Wheel – Several critiques can be made of 
mass spectrometry based proteomics efforts at the start of this thesis 
work. May of many of these critiques still apply to the current field. 
First and foremost is repetition of labor, or so called “reinvention of the 
wheel”. Sequest (1994) is widely accepted as the first statistical 
algorithm for shotgun proteomics-based peptide and protein 
identification. More than a decade later seemingly far too many 
research groups are still actively developing algorithms that are 
fundamentally similar to Sequest. The ProteomeCommons.org tools 
page provides a list of at least 20 different MS/MS search engine tools. 
All of which are remarkably small evolutions from the original Sequest 
algorithm. Few if any revolutionary techniques have been introduced. 
Even Sequest itself is still often used as a benchmark of novel 
developments. Conceptually is is easy to recognize that Sequest 
should not currently be considered a state of the art algorithm. It is the 
first generation of statistical scoring MS/MS software algorithms, it 
identifies peak lists largely in ignorance of the size or quality of the 
input data set, and even Sequest's author acknowledges deficiencies 
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with the algorithm. Ten years ago Sequest was a great tool for MS/MS 
based proteomics. Currently Sequest alone is not a benchmark anyone 
should use when comparing MS/MS search engine developments, note 
Sequest with PeptideProphet is a special case.  Current MS/MS search 
engines must measure up to significantly more than what Sequest had 
to. The open-source search engines X!Tandem [42] and OMSSA [43] 
provide excellent examples of statistical scoring based on the entire 
set of data being processed. The algorithms are not perfect, most 
manuscripts demonstrate significant benefits to using other 
commercial algorithms, but the open-source algorithms do provide 
both a free and explicit example of the statistical process behind 
MS/MS search algorithms. A refined scoring algorithm named k_score 
for X!Tandem is another noteworthy refinement the provides a much 
more sophisticated scoring metric for the X!Tandem code. It would be 
helpful to see any new MS/MS search engine developed demonstrate a 
significant improvement versus both X!Tandem and OMSSA. Ideally, 
not a questionable 5-10% improvement, but an improvement that can 
not easily be reached by modifying or altering the input parameters of 
the open-source, widely accessible search algorithms. If such an 
improvement cannot be obtained, then any effort invested in the new 
algorithm is of questionable benefit compared to simply using the 
existing algorithms. Unfortunately, the vast majority of MS/MS research 
papers being published seem to demonstrate a marginal improvement 
over existing algorithms – sometimes over nothing but the original 
Sequest – and this type of publication does not seem to be moving the 
field forward. Rather, in my personal opinion, this fuels individual 
groups egos and establishes an environment where significant effort is 
invested in figuring out how to make particular MS/MS algorithms 
appear superior versus a comparable algorithm. With that stated, I do 
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not propose the publication ban of minor evolutions to statistical 
MS/MS search algorithms. Rather it would be nice to see a generally 
accepted sediment that one should not expect to impress anyone with 
a new MS/MS search algorithm. If a group wishes to publish an 
algorithm, they should bear the burden of picking several openly 
accessible data sets and running their algorithm versus other available 
algorithms. Currently this burden is problematic because no clear 
benchmark proteomics data sets have been adopted by the 
community. The Aurum data set presented in this thesis is a good 
candidate, but even it is not yet in widespread use, nor will it be an 
ideal data set until both LTQ/Orbitrap and the MALDI TOF/TOF data is 
published, which is planned in subsequent publications of the data set. 
With the critique stated, the concluding comment regards a positive 
side-effect from the plethora of basically similar MS/MS search 
algorithms. Most active proteome informatics groups have their own 
MS/MS search engine, and are invested in keeping it mainstream use. 
This is best cited by the 2007 and 2008 ABRF iPRG groups (of which 
the author is a 2008 member). The organizing members are tasked 
with comparing MS/MS data sets, which forces cross communication 
regarding results and the similarity thereof. This cross communication 
is good because I think it will accelerate the community realization that 
relatively few significant evolutions in statistical MS/MS search 
algorithms have been realized. It remains to be seen if the iPRG's 
participating community will benefit, but certainly the key software 
developers are aware of each other's work. Hopefully future efforts in 
the iPRG and similar projects in the proteomics community will focus 
on the establishment of benchmark datasets and reusable analyses 
results for peer-review publications that wish to claim improvements in 
MS/MS search algorithms. This would be an excellent cornerstone for 
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journals to build upon and enforce that “novel” algorithms actually 
compare against existing data sets that the publishing lab did not 
produce. It would also alleviate the  burden of asking individual labs to 
acquire and run all current MS/MS search engines including commercial 
products. The results of existing analyses could be made available for 
direct comparison against.
Unacceptable Publication Standards – Another critical 
critique is the lack of reproducibility of bioinformatics analyses, 
primarily due to lack of access to the original data sets. Mass 
spectrometry data sets have quickly grown in size. A single experiment 
can easily generate gigabytes of raw data. No proteomics journal 
currently requires that the full data set accompany a peer-reviewed 
article for publication, nor does any journal currently require that such 
data are published elsewhere. Several years ago this practice would 
not be considered unreasonable given the size and quantity of 
proteomics experiments; however, recent developments in proteomics, 
Chapters 4 and 5, have illustrated efficient methods of both storing 
and disseminating proteomics data sets of virtually any size. Not only 
are the approaches demonstrated, but they are free to use. It is no 
longer acceptable to claim the size of data sets as prohibitive to their 
complete publication. Several journals have made formal 
recommendations  to encourage data sharing to help with 
reproducibility of data analyses. While not ubiquitous, the practice of 
full publication of data sets, parameters, and software used in 
bioinformatics analysis has gained traction to the extent that it may 
indeed soon be standard practice. Use of Tranche goes to greatly 
support this point, and it is possibly the most significant contribution 
this thesis work has provided to the proteomics community.
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Outside of the size of data sets being published, three other 
issues are presented when scientists are tasked with publication of 
their data sets. First is that of protection of unidentified but valuable 
information in the data set. Second is that of the inability of others to 
process the data without access to a vendor's proprietary software. 
Third, is that most data is junk. It is not desirable to establish a trash 
heap of public accessible data – only high quality data should be 
published. It is my opinion that these three arguments are not 
appropriate for those interested in basic science research. Generally, 
all government funded peer-review research should mandate that raw 
data sets be released upon acceptance of a peer-review manuscript 
with the agreement that use of the raw data constitutes formal 
citation. Regarding the first argument, protection of unidentified data. 
The peer-review publication is the authors chance to present a 
complete analysis of the data set. It should be expected that further 
information might be mined from the data, yet it is not appropriate to 
attempt any sort of claim to subsequent use of the data. The Science 
Commons has described why this is not appropriate in detail, and in 
short the answer is that it is ridiculous to try and maintain an indefinite 
chain of citation, permission, and credit for data sets. It is reasonable 
to expect a citation if one's data set is used; however, no formal 
requirement should be maintained. Successful reuse of data sets, 
especially creative reuse, should not be burdened by the originating 
author or groups ego. A best effort system should exist to cite and 
support publishers of data, but data must be complete free for reuse if 
it is actually going to be helpful.
In regards to the second argument, the inability of users to 
process the actual data set. Yes, it is likely that most users will not 
have a license to the original vendor's software. However, if there is no 
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penalty to publishing data (Tranche demonstrates that there is not), 
then it should be published. Some users will be able to access the raw 
data, and in due time the vendors format may become accessible via 
free to use tools. Several examples of this latter case are present in the 
ProteomeCommons.org IO framework presented in this work. Many 
vendors have published binary tools that can process proprietary data 
files and produce open-access file formats. Additionally, several free 
tools were created in collaboration with commercial vendors to expose 
their file format openly. Ideally, it would be nice to have peer-review 
journals request that unaccessible file formats be published in two 
ways. First the raw, unadulterated files. Second, some form of a 
publicly accessible file format. This would enable the vast majority of 
users to freely access the data either with the vendor's own software 
or via the public format. Also, should eventually the plumbing code be 
established to actually access the raw file formats, then they would be 
usable.
In regards to the third argument, avoidance of junk. This is 
complete nonsense. It is not the place of a basic scientist to omit 
portions of data because they do not appear to be meaningful. A 
complete study might not be published due to it not supporting a 
desired effect; however, a portion of a published data set should never 
be omitted because the publishing scientist thinks that it is not 
informative. The peer-review process exists so that others can 
objectively re-evaluate data sets. Without the complete data set it is 
difficult if not impossible to do this task, and,  the integrity of published 
data might be skewed. Computers continue to increase in processing 
power, algorithms continue to improve in performance, and 
bioinformaticians continue to grow our ability to mine data sets that 
would have seemed impossibly large previously. The task of 
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determining junk from valuable data should be left to the community 
to decide in peer-review publication. It should also be freely questioned 
and critiqued same as any other basic science methodology.
Standardization of Statistical Methods – A related, final 
critique is that of standardization of statistical practices for 
determination of false discovery rates and objective high confidence 
peptide and protein identifications – a critique recently emphasized by 
several journals [44-46]. Several early proteomics publications and few 
more recent publications reported simple lists of peptide and protein 
identifications. Such lists of identifications are particularly difficult to 
validate given that one must guess at the parameters used by related 
software packages and that no statistical confidence was assigned to 
the identifications. Most journals have since migrated to a system of 
mandating that any peptide or protein identification be justified with 
objective statistics and that those statistics be clearly described. Due 
in part to these recommendations two false discovery rate estimation 
techniques have become commonly used, mixture models [47] and 
decoy analysis [48, 49]. Further efforts are also currently underway to 
standardize recommendations for statistical practices, namely the 
Human Protein Organization's Statistical Proteomics Initiative (HUPO 
SPI) [50].
In general, all of the aforementioned standardization of statistical 
methods have proven of questionable benefit to the proteomics 
community. The efforts may fruit in due time. However, any published 
standard will continually be subject to refinement and evolution. Much 
time will likely be required before anyone can objectively evaluate the 
success of existing standardization efforts. This opinion is in fact the 
primary motivation for the development of Tranche, Chapters 4 and 5. 
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The belief is that the most significant contribution that statistical 
technique standardization can provide is that of benchmark data sets 
and analyses. Given a proper tool to archive the raw data sets and 
results from proposed statistical analysis, others can much more 
quickly learn how to perform similar analyses. Additionally, journals 
can much more easily mandate comparisons and evaluate the 
techniques employed by researchers. Tranche seeks to properly 
serialized the raw data and analyses files for whatever statistical 
practices are proposed by the aforementioned studies. There is no 
reason that these files can not be saved now, and by saving the 
information, future studies can hopefully be greatly accelerated. The 
truth behind Tranche is that it reflects the belief that there will never 
be a final statistical standardization process. Instead, if the process of 
coming up with new MS/MS search algorithms and  proposed statistical 
standards is made in to a commodity, then the community will more 
quickly reach truly significant developments. This final critique can 
more succinctly be stated as the following. The proteomics community 
seems preoccupied investing time in revising each others work versus 
accelerating community growth.
Introduction of Thesis Work
Motivation for the work presented in this thesis is clearly framed 
around mass spectrometry-based proteomics. By 2005, experimental 
procedures based on the original shotgun proteomics strategy had 
become widespread and related data sets were becoming much more 
accessible to researchers in the field of Bioinformatics. All work 
presented here was done with Dr. Andrews' basic science lab, National 
Resource for Proteomics and Pathways (NRPP), and Michigan Proteome 
Consortium (MPC). The Andrews lab conveniently had and continued to 
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have several state-of-the-art mass spectrometers available during this 
thesis work. When discussing thesis projects it was clear that the 
project would involve gaining experience using mass spectrometers, 
high-throughput proteomics data processing, and dissemination of 
results to the community. 
Early on it was decided that if possible the thesis work should 
avoid the obvious critiques of MS/MS proteomics at the time, most 
notably the lack data sharing and reinvention of MS/MS search 
algorithms. This mindset was of particular importance because both 
the NRPP and MCP were responsible for helping accelerate proteomics 
research and accessibility to proteomics services and software both in 
Michigan and nationwide. Implementation of restricted access tools, 
data sets, and reinvention of existing tools would likely not satisfy 
these goals well. Thus it was decided from the beginning that the 
thesis work would leverage personal prior experience, specifically 
open-source code development and web application (web site) 
development. Ideally, these skills could be used to start an objective 
survey for appropriate projects based on community feedback. 
Synchronously, training on analytical techniques and the experimental 
techniques related to shotgun proteomics could occur while the 
community survey was in progress.
Chapter 2 will introduce the initial survey step, namely 
ProteomeCommons.org [51]. Several related tools and sub-projects will 
also be summarized in that chapter. The work is important because it 
starts this thesis work off in a fashion that follows its own goals. 
Instead of diving directly in to development of the most obviously 
popular problem, processing MS/MS data sets, a fair evaluation of the 
community's resources and efforts is performed. Furthermore the 
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entire evaluation is published in a public forum so that others may 
share in the knowledge I acquired only after building a complete 
website. Chapter 2 starts what will later be shown as a clear trend of 
attempting to accelerate the general proteomics community's growth 
versus pitting the author's intellect and ability to code software against 
that of other research groups.
Chapter 3 details an open-access reference data set, named 
Aurum [52], that was designed to aid in software algorithm 
development for shotgun proteomics. Aurum is also the first dataset 
published in Tranche [53] and a model peer-reviewed, public access 
data set. The entire process of generating and processing the Aurum 
data set is serialized on ProteomeCommons.org in a set of publicly 
accessible files. Same as with development of ProteomeCommons.org, 
the intention behind Aurum was to provide a data set that anyone else 
could easily use. Likewise, the result files from the MS/MS search 
algorithms used to process the Aurum data set are free for others to 
access. The intention is accelerate publications related to Aurum that 
claim benefits compared to the original analysis via reprocessing of 
published results. This type of benefit is in fact shown in Chapter 6 with 
discussion of the Bonanza manuscript.
Chapter 4 and 5 present Tranche and the technical details related 
to Tranche, which have become cornerstones of this thesis work. 
Tranche has thrived because it fills a critical niche in proteomics: 
making data sets accessible independent of file format or original 
software analysis. Tranche has been of particular importance because 
it also enabled the high-throughput data set analysis (Bonanza) in 
Chapter 6. Perhaps most importantly, Tranche enables any proteomics 
researcher to acquire and use the same data sets used for any study, 
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not just the author of this thesis. This has proved extremely popular 
and resulted in rapid adoption by the community and journals. It has 
also made high-throughput proteomics data sets directly accessible to 
bioinformatics groups that do not even own a mass spectrometer.
The remainder of this thesis is broken into six chapters as 
mentioned previously. In short, the first chapter details 
ProteomeCommons.org, its contribution to nucleating an open-source 
community in proteomics, and work to survey the interest and needs of 
the proteomics community. The second chapter details work done in 
parallel with ProteomeCommons.org to develop an open-access, 
reference data set. The fourth and fifth chapters detail the 
implementation and design, respectively, of the Tranche project and 
the major impact it has had over a relatively short time period. The 
sixth chapter details a novel refinement to high-throughput proteomics 
data analysis, based on ideas designed to take advantage of the 
multitude of data sets stored in Tranche. The conclusion chapter brings 
closure to the discussion of this body of work. Three satisfying themes 
are full explored, first the successful inference of what type of tools 
would actually be widely used, second, the effect that Tranche has had 
on sharing public data and its consequences, and third, successful 
avoidance of 'reinventing' a MS/MS search algorithm in favor of refining 




The diversity of biomedical problems to which proteomics 
technologies are being applied, coupled with the limited tools 
available, has lead many groups to develop their own scripts and 
software for analysis of proteomics data.  This demand for new tools 
and the limited sources available has led to efforts by a number of 
laboratories to take advantage of the benefits derived from open 
source code development. This recent increase in open source projects 
for proteomics tools reflects the need for a broader range of tools and 
the reliance of proteome technology development on computational 
infrastructure.  The open source effort has been paralleled by release 
of standard datasets and development of data format standards, both 
of which benefit algorithm and tool development.  These aggregate 
efforts raise several issues currently being addressed by the 
proteomics community,  including mechanisms for file standards 
development and support, data dissemination and annotation, and 
project organization and management. However, when I began my 
thesis work, all these efforts were in their infancies and we determined 
that a centralized resource could be developed that would help unify 
many of these efforts and provide access to the new resources that we 
and others were developing. ProteomeCommons.org was created as a 
tool to bring existing data archiving and dissemination functionality to 
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 the proteomics community in a fashion that requires minimal effort to 
use with existing code and data sets.
Introduction
ProteomeCommons.org [54] was placed on-line in 2004 and has 
grown to archive over 100 software projects and includes several 
hundred links to other  resources. The basic site includes a simple web 
interface accessed via a web browser. The website currently receives 
over 5,000 visitors per week with over one thousand unique visitors.
ProteomeCommons.org was originally designed to help facilitate 
communication withing the proteomics community, act as a nucleation 
site for the open-source proteomics community, and to survey the field 
for existing tools, groups and data sets. Currently, 
ProteomeCommons.org is most often accessed for its aggregation of 
proteomics news, listing of available proteomics software, and indexing 
of proteomics software – primarily data hosted in Tranche. The site acts 
as a portal to many resources developed by our research group as well 
as many other groups and hosts several development projects.
Methodology
ProteomeCommons.org is designed to be as simple as possible to 
use. No registration is  required and no extraneous information is 
mixed in with content.  Users can use the entire website without 
needing anything more than their web browsers and access to all 
content is completely free. Combined with the free open access to 
content is an embedded peer review system. All content published on 
ProteomeCommons.org is manually verified by members of the 
proteomics community to ensure that the quality of content is as high 
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as possible. This process is largely done by the National Resource for 
Proteomics and Pathways (NRPP) and volunteers. While it is not as 
stringent as most peer-reviewed journals, the process is designed to 
limit abuse of the resource and maintain a helpful level of service.
Key features currently available on ProteomeCommons.org 
include news aggregation, indexing of tools and links, free websites for 
projects, public archives for data, e-mail lists for communication, 
several open-source proteomics tools projects, distributed downloads 
and Google-like searching of content. The bulk of these features are 
based upon free tools and protocols that are commonly used in 
existing open-source software (OSS) communities. The website itself is 
coded in the Java programming language and JSP and hosted by the 
freely available Apache Tomcat web server, http://tomcat.apache.com. 
Most all of the projects supported by ProteomeCommons.org are also 
coded in Java with the exception of the Google provided e-mail lists, 
website usage tracking, and website indexing. Over the lifespan of 
ProteomeCommons.org it has become clear that many software 
packages exist for attempting to infer information from MS/MS data 
sets, and in contrast, a serious lack of software existed for interpreting 
results from such software, acquiring data to process by such software, 
and converting data into appropriate file formats MS/MS programs.
Largely due to the goals of the NRPP, ProteomeCommons.org has 
been able to become a hub for development of many desirable 
software services for the proteomics community. Several of these 
projects would have been very difficult, if not impossible, to justify 
independent funding. Primarily because many of the projects represent 
a logical step involved in solving or enabling research for the larger 
problem of high-throughput proteomics. Alone, the steps lack the luster 
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associated with most basic science experiments, and when combined 
into a single projects, rarely were the steps polished significantly. 
Detailed here are three of the six primary sub-projects started on 
ProteomeCommons.org as part of this thesis work: the Java Analysis 
Framework (JAF) framework, the Input and Output (IO) Framework, and 
Peptide Finite State Machine (PFSM). Each of these projects was 
documented in publications in peer reviewed journals. The remaining 
projects, Tranche, Aurum and Bonanza, are covered in subsequent 
chapters of the thesis.
Java Analysis Framework (JAF)
The ProteomeCommons.org Java Analysis Framework (JAF) [55] 
provides a library of freely usable, open-source Java code that 
abstracts information regarding commonly used atoms, stable isotopes 
of atoms, residues, and modifications to residues. The code initially 
started as an application programming interface (API) for accessing 
this information and speeding up development of tools that relied on 
calculations such as the masses of peptides and proteins, SNPs of a 
protein sequence, theoretical isotope distributions of ions observed by 
mass spectrometry, and references for atomic weights and residue 
compositions. The JAF currently provides both the aforementioned 
programmer's API and several user tools.
The user tools provided by the JAF include mass spectrometrist-
friendly HTML references for the common atoms and atomic isotopes, 
the common amino acids and known modifications of those amino 
acids and combinations of common amino acids, including mass shifts 
associated with residues on the N-terminus of C-terminus of peptides. 
In addition to the on-line HTML references the JAF provides a tool for 
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dynamically finding combinations of residues that match a particular 
mass within a given mass tolerance. The JAF also provides a peptide 
calculator utility that looks just like a normal calculator, but can be 
used to calculate molecular weight of peptides, the mass of charged 
ions (allowing any charge) in mass spectrometry, the theoretical pI  of 
peptides, and the fragments of the peptide's sequence assuming it was 
cleaved by any number of a given set of enzymes.
All of the user tools the JAF provides run directly on-line, through 
a web browser. The JAF takes advantage of the Java Web Start 
technology, which allows for robust, Java-based tools to automatically 
run directly on-line.
ProteomeCommons.org IO Framework
The ProteomeCommons.org IO Framework [56] is an freely 
usable, open-source framework for processing protein information and 
data produced by mass spectrometers. The framework initially started 
as a Java API that developers could use to convert between various 
mass spectrometer file formats, including MGF, PKL, DTA, mzData, 
mzXML, T2D, and more. The framework also provides a set of utilities 
for reading through sets of protein sequences saved in formats such as 
FASTA, and tools for manipulating proteins sequences in ways such as 
performing proteolytic digests, generating SNPs of protein sequences, 
and generating possible modifications of known protein sequences. In 
addition to the programmer's API the framework now provides user 
tools for performing conversion between different mass spectrometer 
output formats and dumping raw data into easily accessible formats 
such as mzData, mzXML, and plain-text. The primary data conversion 
tool is available on-line directly from ProteomeCommons.org and it 
23
requires no installation for users to be able to convert existing mass 
spectrometry data into a different format.
Peptide Finite State Machines (PFSM)
The peptide to protein inference is limited by many parameters 
with a significant hurdle being the time required to process a data set. 
Typically a MS/MS proteomics search engine will scan an entire library 
of protein sequences one at a time, modeled after Sequest [57], which 
can result in a prohibitively long period of data processing. This 
problem is of particular concern when considering larger data sets may 
contain hundreds of millions of protein sequences saved in a file that is 
of gigabytes in size. Ron Beavis and his optimization work with the X!
Tandem search engine [58] is perhaps the most well known example of 
addressing this particular issue while not sacrificing the statistical 
sensitivity of the tool. Inspired by this work, research into creating a 
regular expression based pre-filter for MS/MS data analysis was done 
[59]. The work leveraged a practical computer science algorithm tactic 
involving suffix trees and construction of a regular expression to 
simultaneously search an entire set of spectra against a library of 
protein sequences in the same time as searching an individual 
spectrum. Figure 2-1 illustrates more intuitively the core concept with a 
cartoon.
If each MS/MS spectrum is treated as a fragmented set of amino 
acids, it is possible to convert an individual spectrum into a single 
regular expression [60] that accounts for all theoretical fragments. A 
convenient characteristic of regular expressions is that multiple regular 
expressions can be combined into one regular expression and applied 
to any set of input strings, e.g. protein sequences, with the same 
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efficiency of a single regular expression. Thus, an entire set of MS/MS 
spectra can readily be combined down to a single regular expression 
that can filter a protein database for relevant sequences. The final step 
is for the MS/MS search engine to be applied to this filtered, 
presumably much smaller, set of sequences in order to infer the most 
correct peptide and protein identifications.
The PFSM strategy was demonstrated to work well on shotgun 
proteomics style data sets generated from an MALDI TOF/TOF mass 
spectrometer. Search time requirements were shown to drop from 
hours to a few minutes, and the majority of resulting peptide and 
protein identifications remained the same. The work is certainly 
successful; however, it was quickly discovered that many MS/MS 
search engines rely on statistics derived from the entire set of protein 
sequences analyzed. Utilization of PFSM as a pre-processing step for 
these search engines could significantly change the search results. In 
order to truly realize the benefit of PFSM pre-filtering use of the 
algorithm would have to be restricted to particular search engines or a 
custom statistical analysis would need to be developed. A strong desire 
still persists to avoid development of yet another MS/MS search 
engine, and this effort was not pursued with PFSM. Rather efforts were 
initiated to work with existing MS/MS search engines in a method that 
would leverage existing statistical scoring algorithms.
Conclusion
ProteomeCommons.org has established itself as a beneficial 
resource for the proteomics community. The website brings several 
modern tools for collaboration and data dissemination to researchers in 
proteomics. ProteomeCommons.org also acts as one of the largest and 
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most comprehensive listing of existing proteomics on-line tools and 
software packages. Another significant benefit of the website is that it 
acts as a sponsor for several open-source software efforts aimed at 
building freely accessibly tools for common proteomics-related work. 
Many of these tools have been used by several different research 
groups. Most notable of such projects is the Tranche project, which 
currently acts as the repository for thousands of proteomics data sets 




A current focus of proteomics research is the establishment of 
acceptable confidence measures in the assignment of protein 
identifications in an unknown sample. Development of new algorithmic 
approaches would greatly benefit from a standard reference set of 
spectra for known proteins for the purpose of testing and training. Here 
we describe an openly available library of mass spectra generated on 
an ABI 4700 MALDI TOF/TOF from 246 known, individually purified and 
trypsin-digested protein samples.  The initial full release of the Aurum 
Dataset includes gel images, peak lists, spectra, search result files, 
decoy database analysis files, FASTA file of protein sequences, manual 
curation, and summary pages describing protein coverage and 
peptides matched via MS/MS followed by decoy database analysis 
using Mascot, Sequest, and X!Tandem. The data is publicly available for 
use at ProteomeCommons.org.
Availability
The Aurum Dataset is freely available for use in its entirety from 
ProteomeCommons.org. On-line versions of the data may be found at 
http://www.proteomecommons.org/current/553/index.html. 
The ProteomeCommons.org Tranche network is used to provide
27
 fast downloads of the data and to get a verifiable, exact copy of the 
data described by this manuscript. The Tranche hash for the Aurum 
Dataset is given below.
HnxUzQuuP7BIqF10aetLtjwnffOwuOMAfDvg2BFmenNe9UeMgprBFh7+
wtpbcWnXqMk2KY8z9VjmwqXYDbQ0pTNqIx4AAAAAASJlaw==
Further information about Tranche and how to use this hash may 
be found on-line at http://www.proteomecommons.org/dev/dfs/.
Introduction
Tandem mass spectrometry (MS/MS) of peptides is currently the 
primary method to identify proteins in complex samples.  Search 
programs such as SEQUEST [61], Mascot [62], X!TANDEM [63] are 
some of the most widely used software packages to identify the most 
likely peptide sequence to match an MS/MS spectrum. Development of 
better MS/MS identification tools is an active area of proteomics 
research [64-67], MS/MS de novo tools [68-70], MS/MS spectral search 
tools [71,72] and MS/MS search result refinement tools [73,74]. All of 
these tools rely on libraries of well-studied MS/MS spectra from a 
variety of instruments with accurate peptide assignments.
Accurate peptide assignments are essential but manual 
confirmation is a time-consuming process that is also subject to some 
degree of operator dependence, and it is not feasible for high-
throughput proteomic analysis. Most commonly, MS/MS algorithms are 
trained on in-house generated data sets that have undergone a variety 
of selection criteria to verify their authenticity. These standard sets are 
often obtained from analysis of commercial protein preparations with 
limited criteria for purity or represent bootstrap efforts that set 
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stringent criteria for results from existing search engines.  Recently, 
several approaches have been proposed to accurately estimate false-
positives and associate peptide identifications with MS/MS spectra with 
high levels of confidence [75, 76]. Development of MS/MS related 
algorithms and tools would greatly benefit from publication of third 
party data sets, particularly well-annotated data sets using these 
proposed approaches to estimating false-positives with as much 
manual confirmation as possible.  Finally, the availability of well-
verified sets of MS/MS spectra can provide the basis for direct spectral 
comparison, which has the potential to be a much more effective 
approach to peptide identification that existing engines that match 
against generated MS/MS spectra and obviates the need for an 
accurate fragmentation model.
Small reference sets of tryptic peptides have been made from 
known proteins [77,78] and larger datasets have been made from the 
yeast proteome [79,80] and human serum proteins collectively in the 
HUPO initiative [81].  While these are useful databases, they are time 
consuming to generate,  and are not all publicly available as a 
reference set.
In this manuscript we describe a publicly available library of 
tandem mass spectra generated on an ABI 4700 MALDI TOF/TOF from 
246 known purified and trypsin-digested protein samples using a work 
flow used for gel-purified proteins. The data are analyzed using the 
Mascot, X!Tandem, and Sequest search engines, and peptide 
identifications are adjusted to 99% true-positive confidence using the 
intuitive decoy database approach described by Elias et al. In addition 
to the peak lists and associated peptide identifications, the described 
data set is also published with the raw spectra, search result files, 
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decoy database analysis files, Scaffold analysis files, and the gel 
images used when checking for protein purity.
Materials and Methods
Proteins -   A selection of 300 sequence-verified recombinant 
human proteins (8-70 kDa.) were obtained from GenWay Biotech Inc 
(San Diego, CA). The proteins were selected by GenWay Biotech based 
on clones that could readily be over-expressed and purified. GenWay 
Biotech provided the sequence verification services and a report for 
each cloned sequence is included in GenWay's product documentation, 
which is referenced by the per protein report included in the on-line 
Aurum documentation. After purity analyses, 246 of the 300 proteins 
were used in the Aurum analysis.  The proteins contained an N-
terminal T7 tag (MASMTGGQQMG also observed as ASMTGGQQR) or 
His6 tag (HHHHHH) and were expressed in E. coli.   Documentation 
provided with the proteins included the name, expressed length and 
the NCBI accession number.  Proteins (2 µg/lane) were analyzed for 
purity by SDS-PAGE stained with colloidal Coomassie G-250 (Figure 
3-1).  The criteria for purity were that at least 50% of the protein was 
at the correct size, the gel lane contained no nearby unrelated protein, 
and at least 95% of the tryptic peptides corresponded to the 
anticipated protein. Images for each of the gels are included in the 
supplementary data, and shown directly on individual protein summary 
pages (Figure 3-2).
For each protein in the Aurum data set a unique GS-number was 
assigned where we used the letters “GS” followed by four digits 
representing a decimal number assigned to the protein. The 
supplementary data includes a table that maps this GS number to an 
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appropriate GI number, NCBI accession number, and Swissprot 
accession number. The GS nomenclature is not intended to represent a 
new standard for referring to the associated protein sequence. Rather 
it is a convenient way to unique identify Aurum proteins for internal 
use within the dataset – independent of accession number or identifier 
changes that might occur in other databases. GS numbers will remain 
static throughout the lifespan of the Aurum dataset; however, use of 
the GS numbers outside the context of analyzing the Aurum data is 
discouraged when either NCBI or Swissprot identifiers are available.
Protein coverage calculations – The entire protein sequence is 
included in each summary file as shown in one file in Figure 2-2. The 
sequence is further colored in order to indicate the peptides that were 
identified and the portions of protein sequence that are not expected 
to be identified. The portions that are not expected to be identified are 
those that have a m/z at +1 charge of less than 900 Da or more than 
2500 Da, i.e. the range that the mass spectrometer is configured to 
ignore. Data analysis for this manuscript is based off a MALDI 
instrument, and the +1 charge state is almost ubiquitously observed 
for ionized peptides. Thus the theoretical m/z of an ionized peptide is 
well approximated to be its molecular mass. The range of 900 to 2,500 
Da is selected for three primary reasons. First, MALDI instruments are 
prone to ionizing matrix clusters that can dominate the lower mass 
region, which often makes it very difficult to identify anything below 
the mass of 900 Da. Second, the instrument used for this analysis is 
tuned to most accurately identify ions with a m/z of 1,800 Da. Ions with 
much less or much greater m/z may report an incorrect m/z to the 
point where it is difficult to use in data analysis. Third, the MALDI 
TOFTOF does not detect higher mass peptides as well as lower and the 
trade off between higher m/z and the amount of sample required to 
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detect the ion appears to be non-linear. Thus, peptides with masses 
higher than 2,500 are problematic due to both relatively inaccurate 
m/z measurements and relatively poor signal strength.
Explanation of protein coverage is important because the results 
section and included protein reports present two types of protein 
coverage information. The first type of protein coverage is a strict 
percentage of the total protein sequence that is covered by observed 
peptides. The second type of coverage, named 'expected protein 
coverage', is the percentage of tryptic peptides that fall within the 900 
Da to 2,500 Da range, i.e. the peptides one might expect to see based 
on the Aurum data acquisition parameters.
In-Gel Tryptic Digestion - Excised gel plugs (0.67 µg protein) were 
placed in 96-well plates and were processed using a MassPrep robotic 
workstation (Waters).  The plugs in the presence of 50 mM ammonium 
bicarbonate underwent the following steps: wash/dehydration with 
50% acetonitrile; reduction with 10 mM DTT; alkylation with 55 mM 
iodoacetamide; wash/dehydration with 50% acetonitrile; digestion for 4 
hours with trypsin (200 ng, porcine, modified, Promega).  Peptides 
were extracted from the gel plug with 1% formic acid/2% acetonitrile 
and concentrated using C-18 ZipTips (Millipore).  Digests were spotted 
(4 replicates) on a MALDI target using α-cyano 4-hydroxy cinnamic acid 
(2 mg/ml in 50% acetonitrile, 0.1% TFA containing 10 mM ammonium 
phosphate) as matrix.  Dilutions of the digests were made at 1/8 and 
were spotted in the same manner.
MS/MS acquisition - Spectra were acquired on a 4700 MALDI 
TOFTOF mass spectrometer (Applied Biosystems).  Spectra were 
acquired for the 8 most intense ions. In a replicate well, after excluding 
the 7 most intense ions, the next 8 most intense ions were analyzed. 
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Similarly, the next set of 8 ions was analyzed for wells 3 and 4.  Known 
trypsin auto-digestion peptides were excluded. This process resulted in 
acquisition of a maximum of 32 spectra per digest, theoretically 29 
unique spectra if sample and MS intensities do not change between 
spottings. 
Data curation – Default peak lists from Applied Biosystems GPS 
software were taken  from replicate wells and were concatenated into a 
single Mascot Generic Format (.mgf) file. In order to map spectra back 
to the original files the the base 16 encoding of individual file's MD5 
[82] hash was set as the MGF file's TITLE field. Additionally, all peak 
lists were converted into a set of .dta files by the 
ProteomeCommons.org IO Framework [83] for subsequent analysis by 
the Sequest. Four different initial searches were performed, each using 
0.5 Da for the parent and fragment ion mass accuracy and with 
oxidation (M,H,W), deamidation (N, Q) variable modifications. 
Iodoacetamide (C) was specified as a static modification. Four follow-
up searches were performed using the similar parameters but without 
iodoacetamide as a static modification in favor of setting 
iodoacetamide and propionamide as variable modifications for the 
side-chains of cysteine residues. Three of the four searches used 
different search engines in an attempt to identify as many of the 
spectra as possible. The two same-search engine searches both used 
Sequest but included the variable n-term protein modifications for each 
of the two purification tags.
The MS/MS searches were performed using Mascot, X!Tandem, 
and Sequest. Two of the initial searches used the concatenated .mgf 
file. One search on Mascot 1.9 and the other search on X!Tandem 
06_9_15. X!Tandem did by default include N-term pyro-glu from N and 
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Q as modifications. The other two initial searches used Sequest. One 
search assuming each protein had an N-term T7 tag and the other 
search assuming each protein had a N-term HIS tag. All searches were 
performed on a decoy database version of the IPI Human FASTA file 
version 3.14. The decoy database was the exact IPI Human 3.14 FASTA 
file with a concatenated reverse version of the same database. Each 
protein in the reverse sequence is noted by appending an “R” to the 
protein's accession number and each protein is changed by reversing 
the order of the amino-acid residues. The ProteomeCommons.org IO 
Framework was used to generate the reverse database. 
Identification of peaklists was based on the decoy search 
strategy outlined by Elias et al. [84] and described briefly here. Each 
search engines peptide identifications were individually ranked 
according to the respective following scores: Mascot's ion score, X!
Tandem's hyperscore, and Sequest's XCorr. Each sorted list is then 
filtered to only include matches that scored above a 99% confidence 
threshold determined as follows. All peptides above the score are 
binned into two categories. Those that are from the normal FASTA 
sequences (i.e. matches without a “R” in the accession) and those that 
are from the decoy sequences (i.e. matches with a “R” in the 
accession). The false positive rate is estimated to be twice as much as 
the ratio of decoy sequences versus normal sequences – twice because 
the decoy sequences only represent half the total database thus 
approximately as many normal sequences are likely inaccurate. An 
example would be the case where 198 normal sequences were 
identified per every 1 decoy sequence, where (1 * 2) / 200 yields a 1% 
false positive rate aka 99% confidence in individual peptide 
identifications. This strategy is presented as an appropriate objective 
analysis of the data set that takes advantage of individual expertise 
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present in different search engines while still normalizing all search 
results to approximately 99% confidence in true positives.
Files used by the respective search engines, including search 
parameter files, peak list files, and FASTA files are included with the on-
line download as described in the availability section.
Results and Discussion 
A well documented set of purified human recombinant proteins 
has been procured and analyzed using a routine gel-based protocol to 
generate a library of mass spectra referred to as the Aurum Dataset. 
At present the Aurum dataset consists of 246 recombinant human 
proteins that have been trypsin-digested and characterized by MALDI 
TOF/TOF.  The MS/MS dataset further underwent what is intended to be 
an objective, community-standard based analysis to generate spectra-
associated peptide identifications and protein coverage information.
The recombinant proteins were expressed in Escherichia coli and 
initial isolation performed by the vendor.  Upon receipt, the proteins 
were analyzed by SDS-PAGE for purity and the dominant bands were 
excised for in-gel tryptic digestion.  Figure 1-1 shows a representative 
gel, where samples GS0372 and GS0376 represent the highest purity 
provided and samples GS0312 and GS0256 represent a moderate-low 
purity. Of the 246 proteins, 181 were represented as a single band and 
were classified as high purity.  An additional 21 were represented as 
evenly distributed doublets.  Analysis of both bands of the doublets 
confirmed that both were forms of the target protein and could be 
placed in the subset of high purity proteins that would be suitable for 
future in-solution digests. The remaining proteins had varying degrees 
of contaminating bands ranging from possible truncation products to E. 
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coli proteins. Only the predominant band was excised and 
characterized. Only proteins for which all tryptic peptides returned the 
correct ID were included in the final protein list.  Gel images are 
included for each protein in the protein's summary page found with the 
on-line documentation for the Aurum Dataset.
MS/MS analysis for the selected gel bands was carried out 
according to the standard analysis procedures described in the 
methods section. Seven different MALDI plates were used, found in the 
documentation with the names “T10467”, “T10475”, “T10622”, 
“T10645”, “T10707”, “T10739”, and “T10761”. Each protein was 
spotted individually at least four times to help ensure the best chance 
of acquiring high-quality spectra for as many of the peptides 
associated with each protein as possible. At least 32 spectra were 
acquired for each protein by collecting data from four separate spots of 
the protein as described in the methods section. Default peak lists of 
the spectra were then extracted for analysis using the MSExtractor tool 
(http://www.proteomecommons.org/current/489) and concatenated 
using the ProteomeCommons.org IO Framework. 9,987 total peaklists 
are included in the resulting .mgf file. Each peak list is identified by the 
original file's MD5 hash listed in the TITLE field of the associated peak 
list in the .mgf file.
Decoy database analysis targeting 99% true-positive confidence 
and using Mascot, X!Tandem and Sequest were performed according to 
suggested guidelines published by Elias et al. The analysis is not 
intended to be a comparison of the search engines used, rather it 
normalizes the results of each search engine to an approximated 99% 
true-positive confidence. All of the peptides from the 99% true positive 
results were aggregated to make the set of all identified spectra. 5,054 
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unique peptide sequences (>50% of all peak lists) were identified at 
99% true-positive confidence with the peptides being identified coming 
from the initial and follow up searches described in the following 
format (initial search)/(follow up search). Note that the follow up search 
is not intended to identify a superset of peptides and the notation does 
not indicate a fraction. Mascot identified 1,682/1,847 peptides, X!
Tandem identified 441/424 peptides, and Sequest identifying 
2,939/2,921 peptides for the T7 tag and 2,937/2,920 peptides for the 
HIS tag searches. No search engine identified a superset of all others 
and a significant gain in highly-confident identifications was obtained 
by combining the three search engines. These results appear to 
support the use of decoy database analysis with multiple search 
engines as an approach to identify more spectra from a dataset; 
however, it is worth emphasizing that these results are not intended as 
a basis for comparison of the search engines used. Various search 
results are expected as each search engine performs analysis 
differently even with the similar settings we used in each search. 
Additionally each search engine has a disparate range of settings that 
might be optimized to change the results of the analysis. The set of 
search engines used is intended only to help increase the number of 
unique spectra identified. For further analysis, the same search result 
files used for decoy database analysis were imported into the Scaffold 
software package (ProteomeSoftware Inc., Portland, OR) for 
PeptideProphet and ProteinProphet-like analysis. Similar results as for 
the decoy database analysis were found and the free Scaffold Viewer 
program may be used to examine the Scaffold files included with this 
manuscript. 
Of the 246 purified proteins 242 proteins had at least one 
peptide identified to the expected cloned sequence and 233 peptides 
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had more than 2 peptides matched to the expected cloned sequence. 
At the most, up to 19 unique peptides matched to a cloned protein. 
The average protein sequence coverage from this analysis was 32% 
and the average protein coverage of theoretically detectable peptides 
is 63%. Theoretically detectable peptides include those that have a 
unmodified m/z of more than 900 Da and less than 2500 Da – m/z 
restrictions specified at the time of data collection. A summary of 
protein coverage and matched peak lists are provided for each protein 
in the supplementary files described by the availability section. Figure 
2 shows an example protein summary. Analysis of the summary files 
illustrates that the majority of proteins have several peptides that may 
be used to identify them from a biological sample assuming that 
similar quantities of the purified protein and or or peptides can be 
obtained. Although some of the proteins have very few, if any, 
peptides that are readily observed. These proteins are of interest for 
further study as they may represent proteins that are difficult to 
identify from a potentially more complex sample using a similar MALDI 
TOFTOF based approach. A simple explanation for several of these 
difficult to analyze proteins is that they are relative small proteins with 
very few, if any, tryptic peptides that fall within the 900 to 2500 Da 
cutoff used when analyzing this data set. Potentially a different mass 
spectrometer such as a ESI-based instrument or a different digestion 
enzyme would provide a more favorable analysis. Other plausible 
explanations could account for the difficulty in analysis of other 
proteins such as poor ionization of the peptides, unfavorable 
experimental protocols for analyzing the particular protein, or even 
experimental error. In any case, the set of poorly identified proteins 
may be of interest for further analysis to identify if they are indeed 
poor candidate proteins for mass spectrometry analysis.
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Further data analysis and summary reports were generated to 
check for common contaminants in mass spectrometry experiments. 
The crap (pronounced “cee-RAP”) 1.0 list of proteins maintained at 
TheGPM.org was searched against the unidentified peak lists. The crap 
list contains approximately 100 proteins including common laboratory 
proteins, proteins added by accident through dust or physical contact, 
and proteins commonly used as molecular weight standards. The crap 
analysis was performed using just the X!Tandem search engine, and 28 
proteins were found with more than 2 peptides matching. In all, 37 
proteins were identified by 1 or more peptides. The proteins primarily 
identified included many keratin proteins and several recombinant E. 
Coli proteins. BSA and Serotransferrin where also found. The complete 
list of crap proteins, the X!Tandem search results, and a set of 
summary pages similar to Figure 2 for the crap proteins are included 
with the supplementary data.
Conclusions
The Aurum Dataset is a high quality dataset of known proteins 
analyzed by a MALDI TOFTOF. The proteins are all human proteins 
expressed in E. coli and purified by N-terminus T7 and HIS tags. The 
proteins further purified using SDS PAGE, individually digested with 
trypsin, and individually spotted 4 times on a MALDI plate. Data was 
acquired to represent at least the top 29 most intense MS peaks, and 
published decoy database analysis was used to identify more than 50% 
of the acquired spectra, approximately 5,000 unique peptides. Based 
on this analysis the majority of proteins can readily be identified, but a 
range exists where some proteins are not as easily analyzed. The low 
end of this range is of particular interest for further analysis as it might 
be helpful for identifying why certain proteins are more difficult to 
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identify from complex samples.
The Aurum Dataset is a valuable contribution for testing existing 
MS/MS algorithms and tools, and the Aurum Dataset will be helpful as 
an objective third-party data set for developing new tools and 
algorithms. The published data set contains all raw and curated data 
used to generate the analysis described by this manuscript and all of 




Facile access to scientific data is a general problem in research 
that is of particular concern to post-genome fields, including 
Proteomics. Current technologies can generate very large quantities of 
data and this rate of data production is rapidly increasing. Most 
proteomics studies are targeted to specific goals and information 
extraneous to these goals, yet present in the datasets, are not 
pursued. A key question has been, how can these very large and useful 
data sets be shared and properly cited? The field of Proteomics 
provides a clear example of coping with this data sharing issue, and 
the tactics used are potential solutions for other fields facing similar 
problems. Presented here is a research project, that  addresses the 
scientific data sharing problem from the perspectives of open-access, 
community based distributed storage. The software implementation of 
these concepts, named “Tranche”, represents a radical change from 
previous approaches for data sharing in the field of Proteomics. 
Tranche provides a scalable, secure mechanism for partitioning the 
responsibility of the data sharing problem across available 
bioinformatics resources in the entire proteomics community. These 
properties enable two critical features: very large data sets can now be 
shared and any data set can be accurately cited and validated as 
unchanged since publication. Tranche also allows individual
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 laboratories to comply with guidelines on data accessibility proposed 
by leading proteomics journals.
Introduction
Sharing large amounts of data and software is a legitimate need 
in the field of proteomics  because replication of search results and 
reanalysis of data rely on access to the original data. Proteomics 
studies are increasingly large, relatively expensive, and, when patient 
samples are involved, often deal with irreplaceable samples. Additional 
information can be gleaned from these large datasets that can be 
valuable for other research efforts.  It is important to archive and share 
such data, particularly publicly funded data, in order to allow 
replication of results and reanalysis with new proteomics software, 
which itself is rapidly evolving and improving. Logically this point is 
straightforward to argue; however, researchers in the field of Protemics 
have additional motivation due to recent guidelines by three of the 
leading journals: Nature Biotechnology, Molecular and Cellular 
Proteomics (MCP), and Proteomics. 
A Nature Biotechnology March 2007 editorial [85] succinctly 
stated, “Beginning this month, Nature Biotechnology is recommending 
that raw data from proteomics and molecular-interaction experiments 
be deposited in a public database before manuscript submission.” 
Carr et al. in Molecular and Cellular Proteomics have repeatedly 
emphasized similar points, but most clearly the 2004 [86] and 2006 
guidelines [87] emphasize, “MCP strongly encourages (but does not at 
present require) the submission of all MS/MS spectra mentioned in the 
paper as supplemental material.” This is in addition to the conceptual 
guidelines outlined requiring sufficient information to document the 
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search engines used and how peptides were identified.
Proteomics also elaborated on similar recommendations in 
guidelines described by Wilkins et al. [88] where academic databases 
and software used must be freely available for use, and furthermore 
“Supplementary material is encouraged. This includes protein 
identification results, expression data, and mass spectrometry peak 
lists.” Concluding with the point that such material will not appear in 
print but on-line via the journal's website.
A point not clearly detailed in these guidelines is how exactly 
proteomics research data (this data being a potential mega-data set) 
can be placed on-line and later accessed as needed. The general trend 
is that a few megabytes of data, ideally annotated spectra and peak 
lists, can be submitted as supplemental data with a manuscript, but 
the journals generally do not provide a mechanism to archive 
gigabytes of supplemental peak lists, raw mass spectra, and related 
files for indefinite public access. Individual researchers are left to solve 
this problem themselves in a variety of ways. Nature Biotechnology 
does recommend a few possible public databases, including Tranche, 
but no concise requirement for what constitutes published 
supplemental data and how to cite and access such data is provided.
Clearly and simply the goals of the Tranche project are now 
stated in relation to these journal guidelines.
1. Tranche can freely and publicly host data sets of any size. 
Downloading and uploading data to the Tranche network is 
limited by the speed of an individual's internet connection.
2. Every data set has a single, unchanging “Tranche Hash” that 
should be used for citation. This identifier is independent of the 
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physical storage location of the data (i.e. not a URL) and the 
identifier verifies that data has not changed since publication. 
The identifier can also be calculated using standard hashing 
algorithms, independent of Tranche if desired.
3. Data can be archived for a reasonable amount of time in the 
Tranche repository. At least several years, but potentially 
indefinitely.
4. Storage is independent of file format or directory structures.  
Conceptually, these points are all a researcher need know about 
Tranche to use it to publish data with a proteomics manuscript. 
Obviously, hosting “data sets of any size” comes with the caveat that 
physical disk space must exist to store the data; however, Tranche has 
been in operation for over a year and has easily hosted thousands of 
data sets including 2005's “largest and most ambitious” [89] data sets. 
Finally, point 2 is of particular note. Tranche not only hosts data but 
does so in an ideal way for scientific citation that also proves data 
hasn't changed since publication – an obvious benefit to peer-reviewed 
data, yet one that is not explicitly mentioned in any of the 
aforementioned guidelines. 
Mass Spectrometry Proteomics Data Repositories
Several efforts exist for hosting proteomics data and annotation 
information.  These efforts significantly differ from Tranche although 
not necessarily in incompatible ways. Notable centralized repositories 
such as PeptideAtlas.org [90], and the Open Proteomics Database 
(OPD) [91]  host various amounts of raw and annotated proteomics 
data. In addition, some information management systems, CPAS [92] 
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and PRIME (https://prime-sdms.org) allow dissemination of discrete 
datasets.  In these examples, the data hosted often comes primarily 
from local collaborators and local installations of information 
management systems. More importantly, all data are hosted by a 
centralized framework. Scaling a centralized database to handle many 
terabytes of raw data can be a challenge, requiring large investments 
in both storage capacity and network bandwidth to maintain effective 
performance characteristics.  Additionally, all data sets hosted by such 
a centralized repository have the disadvantage of relying on the owner 
of the repository(s) to keep it properly on-line. Other notable 
centralized repositories such as TheGPM [93], PRIDE [94], and the 
HPRD [95] exist for hosting filtered versions of raw data and 
annotations of raw data. These resources are quite valuable, but for 
practical reasons, distance themselves from coping with the problem of 
storing the raw data associated with a proteomics experiment.  The 
overhead associated with maintaining a centralized database for raw 
spectra is significant, can interfere with performance and compete for 
resources better dedicated to development of higher level functionality.
Tranche was developed in June 2006 and similar to all of the 
previous tools, the goal was to share proteomics data; however, 
Tranche is not tied to a specific software package for processing data 
or to any particular file formats. Rather Tranche was designed for the 
sole purpose of sharing large sets of files and providing a citation 
mechanism suitable for peer-reviewed scientific literature. 
Furthermore, the intention of Tranche was that it be freely used to both 
mirror and provide data to the repositories previously mentioned, 
ideally letting groups more interested in higher-level data processing to 
not have to worry about storage and transportation of raw data. 
Currently Tranche is used in various ways, including as a data 
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repository, by the majority of the above resources as indicated in the 
example collaborations section of the on-line Tranche documentation.
Results
The ProteomeCommons.org Tranche network went on-line in June 
2006 and after a year of use has approximately 4,500 data sets on-line 
representing close to 2 terabytes of compressed data occupying 
physical disk space. The network consists of 17 dedicated servers 
spanning the globe with an aggregate storage capacity of more than 
60 terabytes. Development of Tranche is funded by NCRR and primarily 
performed at the University of Michigan; however, it is an open source 
project and multiple labs have established Tranche servers that 
participate in the ProteomeCommons.org network. Summarized here is 
the existing core network of Tranche computers, the data hosted on 
the Tranche network, and adoption progress of Tranche in the 
proteomics community. More comprehensive documentation regarding 
all of these topics is maintained in the on-line documentation at 
http://tranche.proteomecommons.org.
Core server development of the Tranche network
Tranche is a Free Open Source Software (FOSS) project where the 
model of use is that one group takes primary responsibility for code 
development and maintenance but use of the Tranche software is 
completely free and others are strongly encouraged to participate and 
reap the benefits of a system designed by bioinformatics experts [96]. 
Initial computer clusters were established around the State of Michigan 
as part of the National Resource for Proteomics and Pathways (NRPP). 
Subsequent storage resources were established by other proteomics 
groups including those working on PeptideAtlas.org [97], GFS [98], and 
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the Human Proteinpedia (humanproteinpedia.org). Additionally large 
scale data collection efforts including the ABRF, HUPO, and NCI MMHCC 
and CPTAC have provided resources for expanding the storage capacity 
of existing Tranche servers in order to adequately store data for the 
associated study.
The Tranche homepage keeps an updated Google map of the 
servers currently participating in the Tranche network, along with 
approximate storage capacity and use per site. Figure 4-1 provides a 
snapshot of this map as an example. It generally does not display 
users of Tranche that primarily seek to download data. Such users can 
also act as servers to share copies of data that are downloaded, but 
generally the map only shows dedicated servers.
Data currently available from Tranche
Tranche has no specific file format restrictions, but the majority 
of the data sets currently in Tranche are derived from mass 
spectrometry. This includes files generated directly by mass 
spectrometers and vendor-specific software programs, processed peak 
list files, output files from MS/MS search algorithms, lists of identified 
peptides and proteins, and other files related to mass spectrometry 
based proteomics studies. Typically all files or a subset of files 
associated with a single peer-reviewed manuscript are put into a single 
directory and that directory is uploaded as a data set.  Figure 4-1 
provides a breakdown of the file types by size that are hosted by 
Tranche. The majority of files are comprised of .raw files (Thermo 
Finnigan Scientific, Waltham, MA), .mzXML files [99], .DAT files in .raw 
directory structures (Waters,  Milford, MA), and .tgz files that are 
primarily the output of Sequest [100] searches. All well-known file 
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formats related to mass spectrometry based proteomics experiments.
Tranche adoption for proteomics data collection and 
sharing
Throughout the past year, the development version of Tranche 
has been used for multiple large-scale data collection efforts. Tranche 
currently contains a complete publicly accessible copy of the 
ambitiously large HUPO PPP data set [101]  and the even larger NCI 
Mouse Proteomics Technologies Initiatives  (MPTI) data set 
(http://proteomics.cancer.gov/programs/mouse/), including the ability 
to download portions of the entire data sets. Tranche was used as the 
primary tool for data collection in the Association of Biomolecular 
Resource Facilities (ABRF) 2005 and 2006 sPRG studies (http://abrf.org) 
and is currently being used for data collection in the NCI Clinical 
Proteomic Technologies for Cancer (CPTAC) project 
(http://proteomics.cancer.gov/) and the HUPO 2007 study 
(http://hupo.org).
Tranche has also aided in the collection and publication of data 
sets referenced in peer-reviewed literature. The recommended use is 
that researchers publish their data prior to submission of a manuscript 
for peer-review, similar to proposed journal recommendations. Many 
groups have elected to do this and several examples are maintained in 
the on-line Tranche documentation. Many more data sets have been 
added post-publication of manuscripts. A data collection effort 
continues at ProteomeCommons.org where many proteomics journal 
research articles are continuously scanned for new data sets that could 
be added to Tranche. The set of journals scanned includes Nature 
Biotechnology, Molecular and Cellular Proteomics, Bioinformatics, The 
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Journal of Proteome Research, and Analytical Chemistry. Currently more 
than 1,200 articles have been scanned for data sets and several 
hundred of the datasets have been requested. A database representing 
this effort is maintained at http://www.proteomecommons.org/data.jsp. 
Discussion
It is rapidly becoming feasible to share and maintain large 
amounts of proteomics data in the public domain – potentially 
indefinitely. Tranche clearly illustrates that the majority of public 
proteomics data can be hosted on-line in both secure and public access 
forms. Additionally, Tranche is free to use either on dedicated 
computer hardware or as a free data sharing service supported by 
participants in the ProteomeCommons.org network. Tranche should be 
considered one viable mechanism for publishing proteomics data sets, 
even very large data sets, that complement peer-reviewed 
manuscripts. Tranche certainly does not satisfy all the aforementioned 
guidelines set forth by proteomics journals; however, Tranche provides 
a critical capability in disseminating as little or as much proteomics 
data necessary to satisfy those guidelines.
Open-access is emphasized heavily in the design of Tranche. This 
holds true to both how Tranche shares data and how the source-code 
was developed and is maintained. Data can easily be accessed from 
Tranche by anyone, and if desired, all data on Tranche can be openly 
migrated as desired to other resources – potentially even a superior 
data sharing system. Within Tranche, users are able to chose if they 
wish to support the network, including the ability to host a copy of all 
of their data and more, or if they wish to take advantage of resources 
provided by others in the community. No centralized repository is 
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required and the network itself does not lose data if a server goes off-
line. It represents a unique tool for open-access sharing of scientific 
data. Any focused scientific community can freely use Tranche to 
efficiently share data to the limits of current computer storage and 
network speeds, and while Tranche supports flexible annotation and 
revision of data, nothing locks data into staying only in Tranche. The 
entire system is a clear example of true open-access scientific data 
sharing for data sets of all types and sizes.
Methods
Tranche was developed as a free open-source software package 
programmed in the Java programming language. Tranche is based on 
agile development philosophies for creating robust code and 
standardized e-commerce encryption algorithms to guarantee privacy 
of shared data and to prevent abuse of servers supporting the Tranche 
network. Complete source-code and documentation for all of the 
features included in Tranche are available from the 
ProteomeCommons.org Tranche website, 
http://tranche.proteomecommons.org. A primer describing how the 
core functionality in Tranche works is included in the supplemental text 
for this manuscript.
Bi-monthly user meetings are held on-line for individuals 
interested in using Tranche, developing Tranche code, reporting 
problems with Tranche, or in learning more about how Tranche works. 
These meetings are also podcast and are available from Tranche or 
iTunes. Specific topics of interest are also recorded and published in 
Tranche and on YouTube.com. See the Tranche website for details.
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Chapter 5
Tranche Implementation and Technical Details
Tranche is a peer-to-peer (P2P) network for sharing scientific 
data. This does mean that expanding Tranche's capacity to share data 
is as straight-forward as adding more computers that run Tranche. 
Theoretically, virtually unlimited amounts of storage space can be 
made available at extraordinarily fast transfer speeds; however, 
practically, the P2P paradigm enables a good storage and data transfer 
mechanism that works with existing computers and can easily grow as 
improvements are made in data storage technologies and data transfer 
media. Tranche's use of P2P does not mean that it should be equated 
to using Bittorrent, Napster, or other popular P2P programs associated 
with non-scientific file sharing, often inclusive of illicit data sharing. 
Tranche was designed from first principles to leverage the benefits of 
P2P for scientific data publication but avoid the stigmas and potential 
risks associated with certain popularized P2P networks. Furthermore, 
Tranche is designed specifically  for sharing scientific data, namely: the 
ability to explicitly cite published data, the ability to verify that data 
hasn't changed since publication, and the ability to prevent potential 
abuse of networked computers including  illicit or dangerous files.
This primer is intended to be a comprehensive introduction to 
how Tranche works; however, many technical details intended solely 
for computer programmers are left to the on-line Tranche
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 documentation at http://tranche.proteomecommons.org.  Additionally, 
the Tranche source-code and associated unit tests provide ideal 
examples for those interested in how particular features are 
implemented.
How Data is Evenly Spread Across the Tranche Network
Computers participating in a Tranche network may have various 
amounts of disk space, potentially less space than is required to host a 
complete proteomics data set. In order to take advantage of all 
possible disk space and to evenly spread data across the Tranche 
network, all files are split into one megabyte (1024*1024 byte) chunks 
– a size smaller than modern hard drives. These chunks are identified 
by a scheme that essentially creates a random identifier (see How 
Tranche Verifies Data) for each chunk that is a fixed length and 
essentially represents a number between 0 and 10181 (approximately 8 
exabytes). Computers on the Tranche network are split to take spans of 
all possible identifiers based on the relative amount of available disk 
space. For example, assume three computers are on-line with the first 
two having twice as much disk space as the third. Tranche would split 
the data that these computers store in the following way. The first 
computer would handle all data with any of the first 2/5 possible 
identifiers. The second computer would store all chunks that have next 
2/5 of possible identifiers. The third computer would store all chunks 
that have the final 1/5 of remaining identifiers.
The assumption is that if the Tranche chunk identifiers are 
random, this means that each computer on the network has a chance 
of being required to store the chunk relative to the size of the span of 
possible chunks it is responsible for. Thus, all computers will fill up 
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equally with 1MB chunks of data regardless of the actual size of space 
available on any one computer. Chunk identifiers are named “Tranche 
Hashes” or “Tranche Hash Strings” in the Tranche documentation and 
the span of all possible chunk identifiers a computer will hold is 
likewise named a “Tranche Hash Span”. Normally, all data on Tranche is 
replicated at least 3 times. In order for this to occur, hash spans are 
split so that at least three different computers on the network will be 
responsible for any given hash span.
Data uploaded to Tranche is split into 1MB chunks using the 
scheme illustrated in Figure 5-1. In order to make the most efficient 
use of  space, data is always compressed, normally using the GZIP 
algorithm. In cases where data must be kept private for a period of 
time, data is next encrypted using the NIST AES 256 standard for data 
encryption. Finally, the resulting files are split into 1MB chunks and 
evenly spread across all Tranche servers as described above.
It is worth noting that the compression and encryption encodings 
shown in Figure 5-1 are not the only encodings Tranche can provide. 
Identifiers in Tranche are based solely on the un-encoded data, 
meaning that at a later time Tranche can arbitrarily change 
compression, encryption schemes, or any other encoding without 
invalidating existing Tranche hashes. This abstraction of encodings is 
purposely done so that user data can later be re-compressed, re-
encrypted, or re-encoded if a more appropriate algorithm is desired. 
This even allows for encodings that are not yet invented.
How Tranche Quickly Finds Data Shared On The Network
Use of Tranche hash spans does more than provide an elegant 
mechanism for evenly distributing the contents of files. The hash spans 
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also provide a convenient mechanism for quickly determining what 
servers should have particular chunks of data. Periodically the Tranche 
tools query servers on the Tranche network to obtain a list of what 
hash spans are configured for all servers. This list is typically very 
small, a hash span or two per server, and generally needs to be 
downloaded only once and cached for reuse. Based on the list of hash 
spans, the Tranche tools can very quickly look up the location of the 
data on the network. Instead of having to ask all servers if they have a 
particular chunk of data, the Tranche tools can simply scan the cached 
hash spans and ask exactly which servers should have a particular 
chunk of data. Those severs can then be queried appropriately to 
access those data. Likewise, when uploading data, the same cached 
hash spans can be used to very quickly determine exactly what servers 
should get a copy of particular data chunks.
We refer to this technique as an “index-less” approach because 
there is no requirement for a single server to maintain an index of 
where all of the files in Tranche currently are. For example, consider 
how Google works when looking up data. Google periodically indexes 
as many websites as possible. When a user wants to find a particular 
web page, e.g. a proteomics website, the user would enter a query on 
Google's homepage. The magic behind Google's search then takes 
place where hundreds of databases are likely queried to find the most 
relevant websites and a list of those websites is presented to the user. 
Google is required in this process because web servers are allowed to 
store any file. There is no way to know where a file is without 
consulting a third party index. In Tranche, there is no need for a tool 
such as Google when trying to download or upload data. Instead each 
server has a defined range of files that it hosts. When the Tranche code 
wants to download or upload it can look at the list of pre-defined hash 
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spans and know immediately where to upload or download data. Figure 
5-2 enforces this concept with a figure that uses the English alphabet 
as model for Tranche hashes.
Note, a tool like Google can be generally helpful on a Tranche 
network for finding semantic information and this is why 
ProteomeCommons.org provides the meta-data indexing service, which 
is conveniently also indexed by Google. While Tranche can quickly 
download and upload data appropriately, the hash span mechanism 
doesn't allow for queries such as “show me all data from the organism 
Mouse” or “show me all data from ThermoFinnigan Scientific LTQs”. A 
third party tool can enable such queries by scanning all of the data in 
Tranche and examining the contents for meaning. Tranche also has a 
general mechanism for associated meta-data with files on the network. 
This allows arbitrary standardized annotations, e.g. 
ProteomeCommons.org's format or mzXML or MIAPE, to be directly 
linked to files hosted in Tranche. The benefit being that third-party 
index tools can systematically see these links and choose to read the 
associated, standardized annotation if the format is understood. 
Furthermore, data standards in proteomics (and general) are in a state 
of flux. By linking arbitrary annotations to files, Tranche provides a 
mechanism for accommodating any new data annotation scheme.
How Tranche Verifies Data
It is the author's opinion that Tranche provides an invaluable 
mechanism for sharing raw and processed data files.  Aside from 
handling large data sets for publishing scientific data, most 
researcher's simply don't know that they can ask for verification that 
data hasn't changed since publication. Tranche hashes assure with an 
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extremely high level of certainty that cited data has not changed since 
publication. Furthermore, this is done using standard digital hashing 
algorithms that aren't specifically tied to Tranche. This means that 
regardless of whether Tranche is used as a repository for a specific 
data set, a Tranche hash can be recalculated easily by anyone and be 
used to prove that data hasn't changed since publication. Stated in a 
different way, if data is initially published in Tranche and cited using a 
Tranche hash, it doesn't matter if the data is migrated later to a 
different repository. The data can still be checked to ensure that it 
hasn't changed since publication with or without Tranche.
A Tranche hash is nothing more than the physical bytes of output 
from three independent  hashing algorithms concatenated with an 8 
byte representation of an unsigned long (8 bytes or 2^64) appended to 
the end. Figure 5-3 provides an example. The three specific algorithms 
used are MD5 [102], SHA-1 and SHA-256 [103]. The unsigned long is in 
little endian format. It is worth noting that both MD5 and SHA-1 are 
currently considered theoretically  “broken”, loosely meaning that 
relying solely on them is no longer appropriate for digital hashing. 
However, practically, MD5 and SHA-1 exploits are largely tied to 
content bloating where the hash can be replicated by appending more, 
sometimes ridiculous amounts, of data to the end of a file. Inclusion of 
the file length in the Tranche hash prevents such abuse. Additionally, 
regardless of MD5 or SHA-1 potential faults, the Tranche hash includes 
the SHA-256 algorithm which is currently considered safe and one of 
the best digital hashing algorithms available.
Finally, one minor point needs clarification. The aforementioned 
hash algorithms work on one file at a time. This poses a problem if one 
desires to upload multiple files as a data set, which is commonly 
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expected with proteomics data. The solution Tranche provides is that if 
multiple files are upload the following is done. First, each individual file 
is uploaded and the hash is recorded. Second, all of the recorded 
hashes are saved to a file that in Tranche terms is named a “project 
file” (top right in Figure 5-1). Third and finally, the newly made project 
file itself is uploaded to Tranche. In order to cite or download the entire 
data set one need only cite the project file. The exact algorithms 
previously described can be used to validate that the file's contents 
haven't changed, and thus the list of hashes in the file are inferred to 
be legitimate. The files represented by that list of hashes can then be 
downloaded and validated automatically to rebuild the entire data set.
Why Tranche hashes are well suited for publication and 
why they look like long strings of gibberish
Tranche hashes are almost always encoded in either Base64 or 
Base16. This is because the raw bytes that represent a Tranche hash 
are not suitable for publication in a peer-reviewed manuscript. Often 
the publication's character encoding does not allow all byte values to 
be shown, but more practically, it is of questionable benefit to present 
readers with characters they have never seen before or cannot easily 
type on a standard keyboard. The solution is to convert the raw 
Tranche hash bytes into a set of English-friendly characters, which is 
exactly what Base64 and Base16 provides. Figure 5-3 provides an 
example of such a Base64 representation.
Another reason Tranche hashes are presented in Base64 or 
Base16 is that these two encodings specify exactly what characters 
can be used to represent the underlying data, Base 16 allows a-f and 
0-9 (16 different characters) and Base64 allows a-z, 0-9, and a several 
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more (64 different characters in all). Both encodings do not allow the 
hyphen “–“ or blank space “ “ or the greater-than symbol “>”, which 
are by far the most commonly inserted characters in formal 
publications or e-mails. For example, if a line of text is too long, 
normally a formal publication hyphenates it and makes two lines. 
Similarly, an e-mail will often break up long text and insert “>” to 
symbolize a reply to a previous message. Both of these cases are 
logical ways that a Tranche hash will get munged via publication; 
however, both cases are easily prevented if the Tranche hash was 
originally in either Base16 or Base64 format. The fix is as simple as 
throwing away known bad characters (i.e. “–“, “ “, “>”) and 
reconstructing the valid Tranche hash.
Finally, it is worth noting that URLs, the most commonly used 
mechanism for currently citing data, have no such ability to be 
reconstructed if damaged by e-mail or publication formatting. 
Additionally, URLs have the critical flaw that they normally provide no 
mechanism for formally checking that data has not changed since 
publication. The data a URL points to can easily be changed by 
whoever owns the corresponding web server. Considering these two 
faults it can be inferred that URLs are not appropriate for publication of 
peer-reviewed scientific data compared to a Tranche hash or similar 
solution.
How Tranche prevents abuse of computers on the network
Tranche provides a unique best effort system for preventing 
abuse of the network. The term “best effort” is used because abuse 
prevention is an ongoing process and should not be inferred to mean 
that Tranche can guarantee that illegal MP3s will never be published on 
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publicly funded servers. Further explanation is required. What Tranche 
provides is support for e-commerce grade digital signatures of data. 
More plainly put, Tranche uses the same mechanism used by the on-
line banking industry to encrypt web page traffic that contains 
sensitive information. This is possible because the related algorithms 
are public standards. Thus data that is hosted on Tranche is allowed 
on-line and archived if and only if it comes from a trusted source. 
Furthermore, every bit of data in Tranche is digitally signed by at least 
one person. This allows data to be revoked if it is ever discovered that 
an individual is abusing Tranche resources.
The entire digital signature support is based on the X.509 
standard [104] and public key cryptography [105], which means 
Tranche users must have a X.509 key in order to add data, delete data, 
or do anything other than download data. That is how trust is 
established when data is being uploaded and it works because only the 
owner(s) of a particular Tranche network can create new upload keys. 
In the case of the ProteomeCommons.org Tranche network, only the 
group collaborating at ProteomeCommons.org can make new X.509 
keys that will work on all servers. Occasionally, customized tools are 
provided that make it appear like no upload key is required, but the 
tool itself is simply hiding use of an appropriate key. Finally, these X.
509 keys have a limited lifespan, which means that it is trivial to let a 
user upload or modify data for a fixed period of time, say pre-
publication, and ensure that the user will lose such privileges later, say 
post-publication.
What cannot be provided by Tranche or the X.509 standard (or 
on-line e-commerce web sites for that matter) is that illegal or illicit 
information is blocked from signing  by a valid X.509 key. That brings 
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discussion back to the MP3 example. A legitimate Tranche user can 
sign an illicit MP3 and upload it to Tranche. Certainly that file can later 
be revoked at will and the owner of the key abused is unambiguously 
known, but that is the best that can be done at this time. There is no 
method available to currently scan all files and determine if they 
contain illegal content or not. The file format itself cannot simply be 
excluded. MP3s for example are commonly used to publish podcasts, 
including the Tranche podcast that gets published in Tranche. There is 
no method of automatically inspecting all MP3s (or similar potentially 
illicit files), interpreting what the data represents, and finally deciding if 
the information is illegal or not. Some file formats attempt to allow for 
this type of functionality, but the vast majority of scientific data file 
formats, specifically proteomics file formats, do not have such 
functionality. Thus it is impossible to strictly prevent a trusted user 
from uploading an illegal file, although Tranche makes allowances for 
easily dealing with this situation once it is identified.
Tranche provides a best effort solution to preventing abuse. In 
general, the community behind Tranche has little interest in sharing 
inappropriate data; however, Tranche still provides what we argue is 
the most practical and robust mechanism for preventing the sharing of 
illicit data. Most popularized P2P programs do not have similar 
mechanisms (often purposely so), which is why Tranche is particularly 
well-suited for sharing scientific data. Resources supported by public 
funds, particularly government grants, should be as difficult as possible 
to abuse. Tranche does provide a practical approach of ensuring this.
Conclusion and Further Information
The Tranche system acts as a data repository, allowing very large 
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data sets to be efficiently shared by partitioning (slicing) responsibility 
for sharing the data across several computers. Should one large 
computer exist that can handle all data, it can easily be used with 
Tranche to do just that; however, currently, and of more importance, is 
Tranche's ability to aggregate multiple smaller computers to 
accomplish the task of storing and archiving vast quantities of data – 
more than any one group may wish to be responsible for. Tranche 
accomplishes this goal through use of several simple tactics described 
in this manuscript. Tranche is Free Open Source Software (FOSS) and 
the implementations of all of these concepts are freely available from 
http://tranche.proteomecommons.org. Additionally, Tranche was 
developed using agile software development philosophies, meaning all 
features are strictly checked via additional code named “unit tests”. 
These unit tests themselves are all freely available with the Tranche 
source-code and provide an ideal mechanism for proving important 
concepts are implemented as expected and for providing code snippets 
that others can learn from.
The source-code itself is by far the most appropriate 
documentation of how things work, but interested individuals are 
encouraged to ask questions and participate in the Tranche e-mail lists 
and bi-monthly remote Tranche user meetings. Tranche is intended to 
be an open, free tool for benefiting the field of proteomics and science 
in general. The intention is that others will reap the rewards of this 
work, ideally without having to learn the details of how Tranche works, 
and that at least one complete solution to the data-sharing and 





Unidentified tandem mass spectra typically represent 50% to 
90% of the spectra acquired in proteomics studies. These idiopathic 
spectra may fail to yield results for several reasons, including low 
signal to noise ratios, incomplete fragmentation, differences in the 
chemical structures of the peptides, co-fragmentation, among others. 
The class of unidentified spectra representing chemically modified 
peptides are of particular biological interest.  This manuscript describes 
a novel algorithm, “Bonanza”, for clustering spectra without knowledge 
of peptide or protein identifications. It also represents a new approach 
that specifically matches MS/MS spectra independently of precursor 
mass to identify both identical spectra and spectra that are otherwise 
identical but have an m/z shift for the precursor ion (i.e. potential 
modification or amino acid substitution). Furthermore, the presented 
algorithm works independently of a spectral library, allowing for 
additional identifications to be mined from existing datasets and 
approximating trends in both chemical and biological peptide 
modifications. Also described here is  a probability-based scoring 
method and a high efficiency search process. Application of Bonanza to 
a collection of MALDI TOFTOF tandem mass spectra obtained from 
approximately 250 recombinant human proteins expressed in E. Coli 
identified biological modifications as well as chemical artifacts. A
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 similar global analysis performed on isotopically tagged human 
embryonic stem cell extracts also identified trends in biological 
modifications and chemical artifacts. The approach described here 
significantly increases the number of spectra identified, improves 
identification of post-translational modifications or amino acid 
substitutions, provides a global quality assessment, and could be used 
to filter spectra prior to database searches to reduce computational 
times.
Introduction
Database searches of peak lists from tandem mass spectrometry 
datasets rarely results in unambiguous identification of more than half 
of the collected spectra using current extant search engines. The 
current focus is on the fraction of spectra that can confidently be 
identified above a scoring or probability threshold which leaves many 
spectra unaccounted for. The extremely large number of  MS/MS 
spectra acquired in a typical experiment makes it impractical to 
individually account for the unidentified spectra by expert de novo 
analysis. These idiopathic spectra include peptides that fragment 
poorly or have low signal-to-noise levels, but also include unexpected 
post-translational modifications, amino acid substitutions, splice sites, 
artifactual modifications, and the co-fragmentation events that occur 
in analysis of high complexity samples, particularly with tandem TOF 
instruments.  All of these latter categories can be of vital biological or 
analytical importance and represent an opportunity for new 
approaches to intelligently recognize previously unidentified spectra 
that could boost the total number of peptides, proteins, and post-
translational modifications identified.
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Database search algorithms such as X!Tandem [106], Mascot 
[107], Sequest [108], and similar algorithms [109-116] identify a 
significant portion of spectra generated by a MudPIT style proteomics 
experiment.  These search tools generally work by matching the 
observed fragment masses for particular parent ions to the theoretical 
fragment masses calculated from an organism-specific proteome 
database. It is not uncommon to have the majority of the spectra left 
unidentified. Explaining why this subset of spectra remains 
unidentified, and, more importantly, creating tools that assist in their 
identification, benefits the proteomics community as a whole by 
exposing additional information that search algorithms may have 
difficulty finding.  Because existing search algorithms match 
experimental MS/MS spectra against theoretical MS/MS spectra for 
peptides having the same parent mass, they can miss peptides whose 
primary structures are discrepant due to chemical modifications, amino 
acid substitutions, or other reasons.  Most search engines attempt to 
address this problem by allowing post-translational modifications and 
substitutions to be specified.  When variable modifications are 
specified, the search space rises exponentially, with increases in 
search time and false positive rates which has led to development of a 
number of approaches that attempt to minimize this effect, including 
iterative approaches that generate a smaller search library that is 
subsequently evaluated for modifications.  For these reasons, it is 
generally advisable to include a limited number of variable 
modifications during database searches.
Spectral matching tools, as described in this manuscript, can also 
be useful for extending classical database searches by identifying 
unexpected post-translational modifications.  Recent projects by Stein 
et. al (http://chemdata.nist.gov/mass-spc/ftp/mass-spc/PepLib.pdf), 
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Craig et. al [117], Frewen et al. [118], Bandeira et al. [119] and Lam et 
al. [120] illustrate the benefits of examining MudPIT data through use 
of spectral matching algorithms. The approach used in those studies is 
an orthogonal method to thos described above.  In many of the above 
studies (Stein, Craig, Frewen, and Lam) a library of existing, identified 
spectra is condensed into consensus or representative peak lists and a 
subset of the library, often spectra with similar precursor m/z  values, 
is then compared to an unknown peak list in an effort to identify 
matches to the existing library. Unlike database search algorithms, no 
organism-specific proteome database (e.g. FASTA file) is required and 
users need not specify particular peptide modifications.  If a modified 
peptide spectrum is present  in the spectral library, it can be matched 
against the equivalent spectrum from another experiment. 
Additionally, since these libraries hold data collected from laboratory 
experiments, they will exhibit more accurate fragmentation patterns 
and ion intensity values than an in silico peptide fragmentation. The 
improved quality of peptide identifications using spectral matching was 
documented in a preliminary study indicating greatly improved ROC 
profiles for spectral matching over classical search engines [120]. 
Other research such as that by Bandeira et al. begins to explore the 
concept that related spectra, specifically modified and unmodified 
forms of a peptide, often generate similar MS/MS spectra. Through use 
of spectral graphs and looking for long, shared sequences of amino 
acids, MS/MS spectra can be compared for similarity. In cases of high 
similarity the spectra can further be examined for potential 
modifications.
The work described in this manuscript is most similar to recently 
described spectral search algorithms cited above, particularly the 
Bandeira, et al. work, but differs from  previous efforts by addressing 
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the large number of unidentified spectra and the relationship of these 
unidentified spectra to spectra that are easily identified by classical 
search engines.  Presented here is the design and implementation of a 
novel approach that clusters spectra regardless of precursor m/z, 
amino acid residue modifications, or whether the peptide sequence can 
be identified by a database search algorithm. Like the Banderia work 
the intention is to identify potential modifications through comparison 
of spectra, independent of a protein database; however, the approach 
described by this manuscript does not use spectral graphs. Instead, 
result files from existing MS/MS database search engines are post-
processed to infer high-confidence identifications. Subsequently, these 
identifications are clustered to other spectra in order to infer similarity. 
Once similar spectra are identified tentative peptide identifications are 
assigned along with potential modifications that can account for 
differences in the spectra.
Our approach to spectral searching extends existing spectral 
searching in at least the following two unique aspects. First, no 
restriction is placed on the precursor mass when comparing peak lists. 
MS/MS spectra with different precursor masses may be clustered and 
identified. Second, the peak list comparison is based on both the 
observed  fragment ions and on the precursor m/z subtracted by the 
observed peaks, named  the “parent-minus peak list”. The entire 
Bonanza algorithm is further documented in the Methods section along 
with a description of performance characteristics in the Results section.
Evaluation of the Bonanza algorithm is performed on two 
different datasets acquired on Applied Biosystems/Sciex model 4700 
and 4800 MALDI TOF/TOF mass spectrometers. The first data set is the 
Aurum reference data set by Falkner et al. [121]. This data set 
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represents a controlled set of approximately 250 human proteins that 
have been expressed in E.Coli. The peak lists are well documented 
based on decoy database analysis and provide a good trued test data 
set. The second data set is a human embryonic stem cell data set 
collected by A. Yocum in collaboration with the laboratory of Dr. 
Katherine O'Shea at the University of Michigan. This data set 
represents a more realistic set of peak lists obtained in the process of a 
biological experiment.
Experimental Procedures
Pre-processing of Peak Lists – The Bonanza algorithm can be 
applied to any peak list, but preprocessing was applied to the data sets 
analyzed in this manuscript in an attempt to reduce low intensity noise 
peaks and improve memory requirements and processing time 
requirements  of the algorithm. Preprocessing was applied to all peak 
lists to take at most the top two most intense peaks per every 100 Da 
m/z. Of this list only the top 30 peaks were kept per peak list. Peak lists 
with less than 10 peaks were discarded from the analysis.
Peak List Comparison Score – A modified dot product is used 
for comparing MS/MS peak lists. Four key modifications exist. First, 
peaks are matched within an arbitrary cutoff, Δ, by default 0.3 Da for 
MALDI TOF/TOF data. Second, the intensities of each peak in each peak 
list is converted to the portion of total intensity in the particular peak 
list. Third, peaks are partitioned into two groups: matched and 
unmatched. The dot product of the matched peaks is calculated 
without change where  and  are the peak lists being compared and  
and  are respective pairs of matching peaks within the Δ cutoff.
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 The dot product of the unmatched peaks is improvised to be the 
squared intensity of the unmatched peak, either a or b respectively. 
This practice allows for unmatched peaks to penalize the final 
calculated bonanza score.
 The final score, named bonanza score, is the matched dot 
product divided by the matched dot product plus the unmatched 
(modified) dot product.
The fourth and final modification is of particular importance, and 
it is how the bonanza algorithm is capable of finding unexpected 
peptide modifications, typically single residue side-chain modifications. 
When determining if two peaks from different peak lists match or not, 
e.g. for inclusion in the matched partition, two checks are performed. 
First, a check is performed to see if the m/z ratio reported for the two 
peaks is less than or equal to the Δ cutoff. Second, a check is 
performed to see if the respective precursor mass minus the m/z ratio 
of two peaks is within the Δ cutoff. If either of the two checks is 
satisfied for a pair of compared peaks, then that pairing is added to the 
set of matched peaks. Otherwise the remaining peaks are considered 
unmatched.
Confidence Calculation for Valid Clusters – Clusterings 
presented in this manuscript are preformed by comparing all peak lists 
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against all other peak lists for each data set, regardless of if the m/z of 
precursor ions is similar or not. For each peak list, the set of scores of it 
compared against other peak lists is sorted from highest to lowest. The 
sorted scores are then used to approximate the confidence of valid 
clusterings as follows. It is assumed that the highest score will 
represent the most similar other peak list and subsequent scores will 
represent less similar peak lists up to the lowest bonanza score. Based 
on this assumption, the distribution of the 1st best bonanza scores 
should include a mix of both valid clusterings and invalid clusterings. 
Likewise, the distributions of the next best bonanza scores, e.g. 10th, 
20th, 50th, and 100th, for each peak list will also be a mixture of invalid 
and valid clusterings; however, the worse the ranking of the bonanza 
score, e.g. 100th best score, the more prominent the distribution of 
invalid clusterings should be. This idea is predicated on prior 
experience with mass spectrometer data sets and the observation that 
rarely will the same peak list be collected more than a few times. This 
observation is particularly true with the common practice of using a 
dynamic MS/MS acquisition algorithm that purposely tries to avoid 
repetitive collection of the same MS/MS scan; however, it is worth 
noting that occasionally the same peak list will be acquired numerous 
times (10 or more) but very rarely 50 times or more even on a large-
scale experiment.
In order to approximate an arbitrary rate of incorrect versus 
correct clustering, the 1st best clustering score distribution is compared 
against a aggregate of the 10th, 20th, 50th, and 100th best clustering 
score distributions. The aggregate is calculated by using the mean of 
the distributions plus two standard deviations, as illustrated in Figure 
6-1. Given any cluster score threshold an approximate rate of 
estimated invalid clusterings versus estimated valid clusterings can be 
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made. For this manuscript, results are report for an estimated 95% 
valid versus invalid clusterings. Conveniently, this objective measure of 
confidence will automatically account for parameterized changes in the 
delta m/z used when assigning matched and unmatched peaks in peak 
list comparisons.
Estimating modification trends – Bonanza clustered peak lists 
do not necessarily need peptide identifications to provide information 
about the data set. The clusters alone can be used to provide an 
estimate of  the peak lists that are being observed multiple times, 
which implies reproducible artifacts in the analysis. Additionally, the 
clusters can serve as an approximation of trends in the data, e.g. 
common modifications on peptides.  Figure 6-2 summarizes this second 
point. Provided are plots of the m/z differences between peak list 
clusterings with bonanza scores above the approximated 95% 
confidence ratio. Without knowing anything about the data it is clear 
that some m/z differences appear much more often than others. Not 
surprisingly, for the Aurum data set, nominal m/z differences of +/-16, 
+/-17, +/-18, and +/-32 Da dominate the clusters. Using the HUPO-MS 
terminology (used throughout the manuscript), these changes could 
easily be argued to be oxidation of peptides and Glu->pyro-Glu and 
Gln->pyro-Glu of N-terminal residues. Analysis of the MS/MS data and 
associated peptide identifications is later provided along with similar 
analysis describing dethiomethyl as the source of the clusters of 
nominal mass differences at +/-42, and +/-64 Da. However, 
juxtaposition of the Yocum data set, an iTRAQ experiment, with the 
Aurum set provides significant support for the idea that obvious trends 
in Figure 2 may be taken at face value. Dominating the Yocum cluster 
trends are nominal m/z differences at +/-144 Da. These m/z differences 
correspond well to the known iTRAQ4plex modification (~144.1). 
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Subsequent information regarding MS/MS analysis and peptide 
identifications is provided later in the manuscript to further analyze 
these trends.
Peptide Identifications – The Bonanza algorithm is not 
intended as a search engine per se and thus does not have a 
component that performs MS/MS database searching that identifies 
peptides to peak lists. Instead Bonanza relies on other search engines 
to provide this functionality and the Bonanza algorithm is restricted to 
inferring peptide identifications based on clusters of peak lists where at 
least one of the peak lists is identified. This design feature allows 
Bonanza to work with existing MS/MS identification software as a tool 
to help account for more of the observed peak lists. Furthermore, 
Bonanza analysis can also be performed on existing bioinformatics 
analysis, as demonstrated with the Aurum data set, which is 
convenient if post processing a large set of previously analyzed data. 
Bonanza also lessens the requirement to explicitly specify potential 
modifications when performing an MS/MS database search. If both 
modified and unmodified forms of a peptide are acquired in the MS/MS 
analysis then only the unmodified form needs to be identified by the 
search engine. Bonanza can cluster the modified form with the 
unmodified and help infer the appropriate identification. This practice 
is appealing because most MS/MS search engines degrade significantly 
in performance, both in the accuracy of peptide identifications and the 
speed of the searches when multiple partial modifications are 
specified.
Results from three and four MS/MS search engines were 
incorporated into the analysis of the Aurum and Yocum data sets, 
respectively, i.e., Mascot [121], X!Tandem [122], X!Tandem with the 
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pluggable k_score algorithm [123], and Sequest [124]. In the case of 
the Aurum data set, the pluggable k_score algorithm was not used 
because this manuscript is reanalyzing the original search results, 
which do not include k_score. All searches were performed with similar 
parameters (see supplemental data for details) and on the same FASTA 
file. A decoy database search strategy was used as previously detailed 
by Falkner et. al [125]. In short, the strategy combined the August 
2006 Human IPI database with a reversed version of of the same 
protein sequences. Each reversed entry is noted by including “R” in the 
protein's accession number. Searches were performed normally by 
each of the software packages and then filtered to keep only matches 
above a 95% confidence threshold. The 95% confidence threshold was 
determined by ranking the respective search engine results by score 
and counting the number of known decoy matches present. The 
threshold was used where a ratio of 190 (95 * 2) peptide identifications 
exists for every 5 known decoy peptide. The resulting lists of peptide 
identifications are the ones used in the analysis presented by this 
manuscript. The complete search results are included in the 
supplemental information included with this manuscript. These search 
results do contain all search parameters used.
It is important to comment that the decoy strategy we used in 
this manuscript is not an adequate method for comparing the 
individual search engines nor do we suggest the approach as a 
superior peptide identification method. No attempt was made to 
optimize individual performance of the search engines, nor were any 
enhanced search features used to help find unusual potential 
modifications, point mutations, or the like. The aggregate set of 
identifications is only intended to represent a reasonable base analysis 
of the data, something that also represents normal practice for initial 
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searches of similar data sets.
Inferred peptide Identifications – Inference of peptide 
identifications was provided to demonstrate that the vast majority of 
Bonanza clustered peak lists to represent a logical modification of a 
amino acid side chain. In the simple case where only one unique 
peptide identification exists, all other peak lists in the cluster are 
assumed to have the same amino acid sequence. If two peak lists do 
not have the same precursor m/z then the difference between the two 
peak lists is applied as a potential modification that might have 
occurred to any of the residues in the peptide. The “best” match was 
found by summing the intensities of the peaks that match the 
theoretical b- and y-ion series for that peptide. The highest aggregate 
intensity match is considered the best match. In cases where multiple 
candidate peptide identifications were present in the same clusters, all 
were considered when determining the best match. The unchanged, 
original peak lists were used in this intensity comparison. Not the 
filtered peak lists as described previously.
The resulting identifications aggregated from the individual 
decoy analysis and inferred by Bonanza are provided as comma-
delimited files in the supplemental data. The results also include 
statistics for each match that allow for manual examination of the 
inferred peptide sequences. The data tables may easily be opened, 
viewed and column-sorted by either Microsoft Excel or the free 
OpenOffice.org software for simplified manual inspection.
Description of datasets – The Aurum data set is a published 
reference data set by Falkner et al. [125]. Approximately 246 human 
proteins were expressed in E.coli, purified, checked for purity by SDS 
PAGE, the gel bands were individually digested by trypsin, and 
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analyzed individually via a ABI 4700 MALDI TOF/TOF. The data set 
includes a similar decoy database analysis as described under 
Methods. The same decoy database analysis is used by this study.
A human embryonic stem cell data set collected by Anastasia 
Yocum in collaboration with Dr. Kathy O'Shea was used as an 
experimental data set to test the performance of the Bonanza 
algorithm. The data set consisted of three biological replicates that 
were each analyzed in triplicate for a total of nine 2D LC runs with each 
sample being spotted across two MALDI target plates. A total of 18 
plates were used in MALDI-MS/MS analysis via an ABI 4800 MALDI 
TOF/TOF. The data set is of particular interest, because it is expected to 
contain many replicates of the same spectra and derived peak lists. 
Like the Aurum data set, the Yocum data set was digested with trypsin 
prior to spotting on the MALDI target plate; however, unlike the Aurum 
data set the Yocum data set was blocked with MMTS at cysteine 
residues, labeled with the iTRAQ reagent, and the source protein 
samples were not checked for purity via 1D PAGE. Further description 
of the Yocum hESC data set is included in a manuscript pending 
publication. Details regarding the Yocum hESC manuscript may be 
obtained from the communicating author.
Performance Characteristics – The Aurum data set (10,000 
peak lists) was analyzed by Bonanza in approximately 5 minutes, and 
the Yocum data set (42,000 peak lists) required approximately 1 hour 
and 8 minutes. Data analysis was performed on a 2.0 Ghz Pentium M 
computer with 1GB of RAM. The source-code demonstrating the 
Bonanza algorithm is not particularly optimized for speed; however, it 
is designed to take  similar, if not much less, time than the related 
MS/MS analysis. The time requirements for the two data sets presented 
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in this manuscript demonstrate that it is feasible to run the Bonanza 
algorithm in-line with an existing proteomics data analysis pipeline.
Availability
Source-code and documentation for this project as well as the 
Aurum dataset are made freely available under the Apache 2.0 license. 
Copies of these files may be requested from the authors. The data sets 
and result files for this manuscript are made available through Tranche 
(http://tranche.proteomecommons.org).
The files related to the Aurum data set can be downloaded using 
the following Tranche hash.
96rx5lCBh6SNpGyuAsE1fSEn3sDxwmHITFfC9uQMNob12r36Xqg2+uFHJ46Jd
VrZB2/UwdbWvizBfigbzJMtpxV9/AQAAAAAAAAFCg==
The hESC data set (Yocum data set) can be found in  Tranche 
using the following hash.
ClX0eNVtoXZrFA6oixm6tImsBvGtrJi7bZCwwJjohqBGaGZDruH0KkntDx9Mw
CXSDRfNLuajYHTtp90/2WYivOjhCxQAAAAAAAALew==
The hESC data set is not included with the public Bonanza data 
and source-code because public release of the data is pending final 
acceptance of Dr. Yocum's hESC manuscript. The Tranche hash 
provided here references the encrypted project and the files will be 
released for public access when the stem cell manuscript is in press.
Results and Discussion
Several conclusions regarding use of spectral clustering to aid 
analysis of MS/MS data can be drawn from our analysis. The first 
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observation is that Bonanza allows significantly more spectra to be 
identified (484 in the Aurum data set and 3,650 in the Yocum data set) 
than high-confidence decoy analysis alone. Expanding upon the plots 
presented in Figure 6-2, it is clear that many of these newly identified 
spectra are modified forms of identified peptides. While identifying 
these spectra may not contribute to more unique peptide 
identifications, Bonanza does provide a valuable quality control 
mechanism through summation of trends present in clusters of peak 
lists. For example, techniques such as iTRAQ or even reducing and 
blocking disulfide bonds can be globally evaluated for completion – a 
complete reaction should primarily yield a single form of the peptide, 
leaving minimal observable other forms via Bonanza analysis. In 
addition, sample quality can be globally evaluated for extreme 
oxidation, Glu->pyro-Glu, Gln->pyro-Glu and similar, commonly 
observed modifications. It is important to point out that Bonanza's 
ability to provide this global view of data sets is in addition to any use 
of Bonanza to do same-dataset or cross-dataset spectral searches. 
Identification of significantly more spectra can also contribute 
significantly to the quality of quantitative studies by providing 
considerably valid identifications.  In the same manner, it could also be 
used to contribute to peptide scores.
Table 6-1 summarizes the Bonanza analysis including peak lists 
kept after filtering, unidentified clustered peak lists, identified peak 
lists and inferred peptide identifications. This analysis indicates that 
Bonanza is finding matches that were not identified by search engines 
alone, and the included listings of identifications in the supplemental 
material support that these identifications are of similar quality to that 
of the search engines. However, the caveat is that Bonanza is not 
actually finding any new peptide identifications compared to the decoy 
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analysis. The inferred identifications are either modified forms of the 
same peptide or similar spectra that were not identified using search 
engines alone.
Although Bonanza makes no new peptide identifications, it 
provides significant insight into both of the data sets described in this 
manuscript.  It does so by allowing a larger fraction of the spectra to be 
accounted for, leading to identification of experimental artifacts and 
potential post-translational modifications. For example, initial Bonanza 
analysis of the Aurum data yielded the global view in Figure 6-2 a 
where the differences in mass within clusters are binned in one dalton 
increments.  The data shown has major peaks at +/-14, +/-16, +/-17, 
+/-18, +/-32, +/-46,  +/-64, and +/- 128 Da. These major peaks 
represent abundant modifications to peptides in this preparation. Note 
that the mass discrepancies in Figure 6-2 occur in pairs equidistant 
from the origin because the modified and unmodified versions of these 
peptides are not distinguished. Actual modification trends and 
corresponding amino acids can be identified by looking at the trends of 
the decoy analysis and inferred peptide identifications. Table 6-2 
provides a summary of the top residue side-chain modifications for 
both data sets of interest. Clear trends at methionine oxidation (+16) 
not only on methionine residues but also tryptophan and histidine 
residues. Additionally, dioxidation (+32) modifications are also present 
in lower abundances. The potentially mysterious +/-14 Da trend is also 
readily explained by the abundance of propionamide modifications, 
which would have prevented the expected carbamidomethyl 
modification (71 – 57 = 14). The Aurum data set was purified using 
PAGE.
Figure 6-3 summarizes the reasoning behind correctly 
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interpreting clusters with -46 Da precursor differences. Based on 
Lagerwed et. al's [126] analysis. Neutral loss of  -64, or -80 is routinely 
observed for the unmodified, singly and doubly oxidized forms of 
methionine respectively. Further examination of the MS/MS peak lists, 
Figure 6-4b provides an example that contains both -46 and -64 losses 
indicating a 2 Da shift is required to best match the observed b- and y-
ion series. Closer examination of the MS spectrum suggests that the 
neutral loss must be due to incomplete metastable decay prior to 
MS/MS fragmentation, and the intermediate form observed in MS mode 
incorrectly appears 2 Da higher than the neutral loss with only a minor 
peak present at the appropriate neutral loss mass. Bonanza analysis 
uncovered this situation, and interestingly, it represents a modification 
that the MS/MS search engines used in this study can not be told to 
look for. No known mechanism exists in these algorithms to specify 
that a potential modification should be considered that appears to be 2 
Da lighter in the MS scan. 
However, a small fraction of the spectra mapping to the 14 Da 
adduct peak do not contain cysteine but do contain many high quality 
b/y ion series  that confirm methylation of E and D residues.  The 
source of the methylation could be endogenous methyltransferase 
activity in E. Coli which has been reported for expression of 
recombinant proteins in E. coli [127,128].  It more likely arises from the 
colloidal Coomassie Blue gel staining procedure which is performed in 
acidic methanol. No clear evidence for simple amino acid substitutions 
were observed for this data set.  The +/-14 Da trend alone yielded two 
significant insights into this dataset.  While most search engines allow 
inclusion of propionamide as a variable modification, it is not always 
chosen.  Additionally, variable methyl esterification of Asp and Glu 
residues is also provided for, but is not expected and rarely selected to 
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keep search times lower and minimize false positives.  It is also worth 
noting that the mass shift for a Glu for Asp substitution is the same as 
for methyl esterification of an Asp residue.
More, obvious expected trends in the Aurum dataset including 
+/-17 and +/-18 are explained by cyclization of N-terminal Glu and Gln 
residues respectively. Other minor, but significant trends were also 
identified at +/-128 and -/+156 Da and explained by missed tryptic 
cleavages at lysyl and arginyl residues respectively. These minor 
trends were validated by MS/MS analysis and by inspection of the 
original protein sequence FASTA file for dibasic sites. Almost all of 
these were semitryptic peptides or were due to incomplete cleavage at 
dibasic sites (KK, KR, RK, RR). Trypsin can cleave between the two 
residues or on the C-terminal side of the dibasic site.  If Trypsin cleaves 
the latter site, little additional cleavage occurs because trypsin is not 
an efficient exopeptidase.   These minor trends were also observed for 
the Yocum data set, but with lysyl residues being iTRAQ modified.
The global view of the Yocum data set provided in 6-2b has 
several different features than for the Aurum data set 6-2a. 
Interestingly, the significant methionine side-chain neutral losses are 
not present, nor is the significant nominal +/-14 Da peak present. The 
experimental protocol supports both of these observations as the 
proteins were not expressed in E.Coli and the sample was not 
subjected to polyacrylamide gel electrophoresis (PAGE). However, the 
Yocum data set is dominated by nominal peaks at +/-144.1 and +/-272 
Da. The +/-272 Da trend is easily identified as iTRAQ modified lysine 
residues – similar to the +/-128 Da trend in the Aurum data set. The 
+/-144.1 trend corresponds to the mass of the iTRAQ4plex 
modification.  Analysis of the MS/MS data determined that incomplete 
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N-terminal modification by iTRAQ explains the majority of the trend, 
but variable modification of lysine, tyrosine, threonine and serine 
residues (K, Y, T, and S) are also clearly present. Variable modification 
of tyrosyl, threonyl, and seryl side chains has been previously reported 
as known side reactions of the iTRAQ reagent and are included in ABI's 
MS/MS search engine software Paragon [129]. The extent of incomplete 
N-term modification by iTRAQ was anomalous and is attributed to the 
slightly lower pKa value of N-terminal amino groups relative to the 
epsilon amino group of lysyl residues.  Slight changes in pH values of 
reaction buffers can have significant effects on the relative degrees of 
nucleophilicity for these two classes of amino groups. This result could 
also arise from limiting concentrations of the iTRAQ acylating reagent. 
Variable N-term modification by iTRAQ does not seem to affect the 
quantification in this case, but is a cause for general concern since it 
can reduce the number of peptides identified if the search engine is 
not informed to treat N-terminal iTRAQ tags as variable and also 
because slight changes in labeling conditions could  potentially lead to 
significant changes in reactivity.
It is interesting to observe that Bonanza analysis did not account 
for every peak list collected (Table 6-1).  Excluding the singleton 
spectra that are not assigned to clusters, approximately 42% (2,274) of 
the clusters in Aurum and 58% (14,023) of the clusters in the Yocum 
data set are not identified. We propose that these while these peak 
lists represent reproducible fragmentation patterns, they may 
correspond to peptides that could not be identified due to features of 
the search engines or the search parameters selected. They could also 
represent contaminating compounds and peptides, repetitive electronic 
noise, or other analysis artifacts. It is unknown if all of these 
unidentified clusters represent peptide spectra that existing MS/MS 
80
search engines can be enhanced to identify or that the FASTA database 
employed in this study does not contain these genes; however, the 
clusters do represent a reasonable set of peak lists to examine for 
further novel peptide identifications.
Concluding Remarks
This manuscript describes the use of spectral clustering to 
effectively identify protein modifications through a non-targeted 
approach.  When used to identify general trends in mass shifts, it can 
be an effective tool for quality control, identifying chemical artifacts 
and incomplete chemical reactions.  It can also reliably identify post-
translational modified peptides in a non-targeted way without 
significantly increasing the search time.  This approach differs from 
targeted approaches that find only modifications that are specified. 
The quality control application of this approach can be used to help 
improve existing protocols for sample preparation – ideally leading to 
reductions in undesired side reactions or  incomplete modifications.
Spectral clustering allows unanticipated modifications to be 
detected with good efficiency even when they are infrequent events. 
Application of an objective scoring threshold to spectral clustering 
provides an effective data-set specific method of determining correctly 
clustered peak lists. It is important to consider, however, that the more 
abundant a modification is, the more apparent it will be in the mass 
difference plots used to visualize trends in precursor mass shifts.
Beyond the applications highlighted in this manuscript, it is worth 
considering other potential applications of Bonanza-style spectral 
clustering.  Many spectral clusters were observed in this study using 
the Bonanza software for which no member provided a significant 
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peptide identification despite relative confidence in the validity of 
observed clusters.  Often these clusters included common mass shifts. 
Such clusterings are intuitively a good place to attempt and improve a 
MS/MS search algorithms performance because other peak lists in the 
same data set have the same trends.  
Another approach that could also be taken advantage of is to 
improve data acquisition by dynamic exclusion of precursor masses 
corresponding to the major m/z difference trends observed using this 
algorithm. Omitting known analytical artifact peaks can allow 
acquisition of more unique spectra. Alternatively, one could target 
known analytical modification peaks in order to increase the 
confidence of peptide identifications. These tactics could be 
particularly helpful for any data set being analyzed repetitively or that 
has been split into several fractions.
An important assumption that Bonanza makes is that the 
algorithm requires both a modified and unmodified form of a peptide in 
order to identify a modified peptide. This is a reasonable assumption 
for many post-translational modifications, particularly those used to 
modulate function. However, there is a significant fraction of post-
translational modifications that are stoichiometric that would be 
missed in an intra-dataset search.  For the analyses presented in this 
manuscript, clustering was performed within a single data set.  When 
stoichiometric modifications are present, this problem can potentially 
be alleviated through clustering across multiple data sets or by use of 
a spectral library of proteins not post-translationally modified. Finally, 
unclustered spectra have some  value because they will include most 
of the noise spectra which can be useful in  diagnosing  the properties 
of random spectral noise.
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The Bonanza algorithm allows us to discover a large portion of 
the previously unidentified peak lists in the Aurum and Yocum data 
sets. These results indicate that this approach can be of benefit for 
analysis of MALDI tandem mass spectra.  Application of this approach 
to electrospray ionization (ESI) MS/MS spectra is also practical and will 
be pursued in future studies. We found Bonanza's analysis particularly 
useful  because while we did attempt to provide a robust, multi-search 
engine analysis of the initial data set that is limited to high-confidence 
identifications, the use of Bonanza allowed many more unidentified 
spectra to be confidently assigned. Bonanza unambiguously identified 
many analytical modifications of identified peptides without requiring 
the MS/MS search engines to explicitly search for them. The use of 
spectral clustering represents a  considerable improvement in the 
identification of modifications because incorporating potential 
modifications into MS/MS search engines can result in lengthy analysis 
times and an increased number of false positives. The non-targeted 
nature of spectral clustering makes no assumptions about the 
presence of specific modifications and so will allow detection of 
unexpected modifications or even previously unknown modifications.
Bonanza successfully found many expected modifications, 
including oxidation and formation of N-terminal pyroglutamyl residues. 
Bonanza also found a number unanticipated  but retrospectively likely 
modifications, including methyl esterification, certain variable 
modifications by iTRAQ, partial metastable decay during neutral loss of 
oxidized methionine side-chains, and polyacrylamide adducts. This 
implementation of spectral clustering successfully found these 
modifications in a non-targeted way. Additionally, it is clear that the 
non-targeted approach used by Bonanza can provide valuable quality 
control feedback regarding experimental protocols that existing 
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targeted approaches used by MS/MS search engines are not designed 
to find.  The application of spectral matching to accommodate the 
multiple charge states observed for ESI data is a logical extension to 
the algorithm. It is also worth noting that Bonanza is essentially a 
spectral comparison tool. From this perspective, the very efficient core 
algorithms could also be applied to cross data set analysis, acting as a 
spectral matching tool similar to X!Hunter, SpectraST, and the NIST 
peptide fragmentation library tool.
Acknowledgments
The authors wish to thank Alexey Nesvizhskii and Thomas 
Blackwell for helpful discussions regarding statistics and expectation 
values, Katherine O'Shea for collaboration in analysis of the hESC 
samples, and the many others in or associated with Philip Andrews lab 
for helpful discussions regarding the Bonanza algorithm and 
implementation.
This work was supported by NCRR Grant # P41-18627 to the 




The body of work presented in this thesis presents several novel 
advancements in the field of proteomics with a focus is on the 
development of MS/MS search engine algorithms and data sharing. By 
focusing on these topics, the overall field of proteomics was reduced to 
several tractable problems, which were addressed by this work. Clear 
themes of open-access, open-source, and building upon existing tools 
are present in each project. These themes are similar in importance to 
the scientific work itself because it makes the overall body of this 
thesis work more palatable for others, potentially even extend. 
Certainly the success of the Tranche project is largely due to the 
openness of both the source-code and the data that is shared by the 
tool.
The ProteomeCommons.org website continues to act as a 
community resource for general dissemination of proteomics 
information, including tools such as the JAF, IO Framework, PFSM, 
Aurum data set, and Tranche. The website itself is in a maintenance 
mode with regular updates relating to news, tools, and data sets. It 
does not appear as the web site's more developer orientated 
resources, namely the subversion repository, are tools that many 
individuals in the proteomics community desire; however, the news, 
tools, and data sets continue to drive more and more traffic to the 
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website. It is fully expected that ProteomeCommons.org will remain 
operating in its current capacity for as long as the National Resource 
for Proteomics and Pathways (NRPP) exists. Maintenance of the 
resource is relatively easy compared to the amount of use the site gets 
and the benefits it has for the proteomics community. Overall, a 
successful web site and lasting resource for the community.
Out of all of the tools developed on ProteomeCommons.org the 
Tranche Project is perhaps the best example, and it certainly gets the 
majority of use. Prior to Tranche it was difficult to easily publish and 
associate a complete data set with a manuscript. Now, it is relatively 
easy to accomplish this task and resources such as 
ProteomeCommons.org even provide an index of all such resources. 
This represents a fundamental shift in the way that scientific data sets 
are shared. Data transfer is greatly accelerated. It is now possible for 
anyone to access the raw published data and it is relatively easy to 
ensure that the data persists indefinitely. A further, very important, 
point is that Tranche does not fundamentally change the concept of 
data sharing in science. Rather Tranche's role is to greatly accelerate 
the process of sharing data and resources. Previously the plumbing did 
not exist for easily sharing files. Yet, if sharing was desired groups 
would agree upon a collaboration and cumbersomely figure out a way 
to send the required information. Currently with Tranche, if data 
sharing is desired, groups still agree upon terms, then simply click 
upload or download for the appropriate data sets. Nothing is 
fundamentally different about the data itself or the negotiation of 
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collaboration. This point is important because it is often missed. 
Primarily, I believe, due to the technophobia of researcher's that have 
long been entrenched in their computer-less discipline. This is likely the 
largest obstacle to overcome for widespread adoption of Tranche and 
the acceptance of a revolutionary approach to scientific information 
sharing. There is likely no easy way to bypass this obstacle; however, 
ease of use and open-source and open-access are all key features of 
Tranche that will facilitate its adoption. It is likely that the technology 
will always remain a mystery to many users, but the integrity of the 
tool's code and freedom of use are readily accessible concepts that all 
seem to easily consume.
The success of Tranche is not intended to dwarf the results of 
Bonanza. Work on the Bonanza algorithm shows great promise for 
leveraging the vast amount of data in Tranche and refining existing 
analyses to discover many previously unidentified peak lists and 
unexpected protein and peptide modifications. Given enough time it is 
likely that Bonanza style analysis will be both common place for MS/MS 
data sets and the technique will occupy much more mind share 
amongst scientists compared to Tranche. Several critical omissions 
existing in contemporary MS/MS database search algorithms. Most 
notably are those of neglect to do cross spectra comparisons and the 
inability to identify post translational modifications that were not 
previously expected. The initial Bonanza example work clearly shows 
that both of theses omissions can readily be resolved. Perhaps not 
completely, but to a very significant extend. Furthermore, obvious 
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future work exists where Bonanza's generic scoring function is 
optimized to account for specific, fragmentation-altering post 
translational modifications such as phosphorylation and glycosolation. 
Continuing this work would be a fantastic opportunity for future 
researchers, and certainly the most logical continuation of this thesis 
work.
It is with great satisfaction that the software created during this 
thesis work is all available as free open-source software (FOSS). This 
type of tool development is possibly the best method of enabling both 
replication of previous work performed and complete public critique of 
the work – two key components of the scientific method. Conveniently, 
the FOSS model also enables anyone to freely access and use the 
software both in its compiled form and in source-code. This greatly aids 
in allowing other researchers to try and use the software. It also lets 
software developers openly critique the design of aspects of the code 
base and or or modify the code to fit specialized needs. Aside from the 
aforementioned benefits, one of the most satisfying aspects of the 
FOSS development for this thesis work is that it was directly supported 
and encouraged by the National Resource for Proteomics and Pathways 
(NRPP), including sponsors in part the National Center for Research and 
Resources (NCRR) and National Cancer Institute (NCI). Hopefully the 
work presented in this thesis, regardless of its scientific value, will 
serve as a good example of how FOSS development can both benefit 
scientific research and accelerate adoption of software tools.
A final, yet clearly present, theme in this thesis is that of working 
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with the active areas of the proteomics community, not in competition 
with. It seems that far too many researchers are still attempting to 
create the next best MS or MS/MS search algorithm that will deprecate 
the reset. If not an obvious fault with this mentality, the Sequest 
algorithm developed in the early 1990's is still considered one of the 
best viable tools. Certainly room exists for competition and 
improvement but it is important to emphasize that the work presented 
in this thesis purposely avoided an obvious reinvention of the wheel – 
primarily due to foresight based on ProteomeCommons.org. The major 
software tools of this thesis work, Tranche and Bonanza, both work with 
existing search algorithms. Tranche enables facile access to data sets 
for both reproduction of prior analyses and better testing against a 
variety of data. Bonanza leverages the work that has been put in to 
existing MS/MS search algorithms and aids greatly in refining the 
parameters used by the tools so that easily identifiable data is not 
missed.
In conclusion, it seems most appropriate to comment on future 
uses and potential development of the tools described by this thesis, 
specifically Tranche and Bonanza. Tranche has matured into a relatively 
stable and widely used tool. The NRPP has funding to continue support 
of Tranche for several years to come, and it is well within reason to 
expect Tranche to thrive as a data sharing tool for proteomics via the 
NRPP. An obvious extension to Tranche would be to extend use to other 
disciplines of science outside of proteomics. Tranche itself is not tied 
specifically to proteomics. Existing efforts are underway to use Tranche 
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in the fields of glycomics and glycoproteomics, metabalomics, and 2D 
gels; however, only time will tell how successful those efforts are. 
Continued use of Bonanza on the majority of data sets present in 
Tranche is an appealing concept. Currently, Bonanza has shown that 
single data set analyses and a handful of data sets from a single mass 
spectrometer can yield significant insights into artifacts present in both 
the mass spectrometer and the experimental protocols used. 
Automated use of Bonanza with most any existing MS/MS search 
algorithm is clearly of benefit; however, this type of automated use 
would be of particular benefit to the proteomics community if the 
majority of data sets in Tranche were analyzed. Such results would 
provide an excellent approximation of search parameters appropriate 
in specific mass spectrometer and MS/MS search engine combinations. 
Furthermore, Bonanza can accurately estimate unexpected peptide 
modifications and unidentified portions of MS/MS data sets that are 
repeatedly observed. It would be intriguing to have such large-scale 
multi-dataset Bonanza results to work with, and the Bonanza work 
presented in this thesis grows into such use or inspires other tools to 




Figure 1-1 – An informatics focused overview of a shotgun proteomics 
experiment. (a) Isolated and relatively purified proteins are prepared. 
(b) Trypsin is used to cleave the proteins into smaller peptides. (c) 
Peptides are ionized in to a mass spectrometer for analysis. (d) Peak 
lists are analyzed with software to infer likely peptides present. (e) 
Further software-based analysis infers likely proteins present.
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Figure 1-2 – Example Mass Spectra. (a) MS and (b) MS/MS. MS data 
typically represents the mass of ionized tryptic peptides. MS/MS data 
typically focuses in on a particular ionized peptide to help determine 
the amino acid sequence.
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Figure 2-1 – Example PFSM figure(A) A peak list missing the second 
ion in the ion series TCGK – or since it is ambiguous, TGCK. The m/z 
difference is annotated with [C,G] because it is assumed that the m/z 
of adding the two residues gives the appropriate m/z to bridge the ion 
series. (B) The graph conversion of the given peak list allowing arcs to 
have multiple residues. (C) The NDFA conversion of the graph in part B, 
illustrating how to convert multiple residue to a single residue 
transitions. The solution is to create all combinations of the residues. 
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Figure 3-1 – An example SDS PAGE check for protein purity. Each 
protein in the Aurum Dataset was checked for purity using a hand cast 
polyacrylamide gel run under protein denaturing conditions (SDS 
PAGE). Multiple proteins were run on the same gel and each protein 
was run in two lanes. Proteins are labeled by their Aurum identification 
number. Only the predominant band was excised, digested, and 
analyzed using MS/MS. A gel image is included with this manuscript's 
data for every protein analyzed and the gels are linked in the protein 
summary report (Figure 2). Gel images also include a protein standard 
ladder in the first lane (approximate kDa labeled) and the percent 
polyacrylamide used to cast the gel in the bottom-right. 
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Figure 3-2 – Protein report file structure and partial example. (A) Block 
diagram describing the information in each of the protein report files 
included with the supplementary information. The intention of these 
pages is to provide a human-friendly summary for each protein 
analyzed. (B). Example protein coverage information from a protein 
summary page. This is only a portion of the summary page highlighting 
total protein coverage and coverage of expected peptides. Not shown 
in the figure are the complete statistics, peptide matches, and links to 
spectra, peak lists and other documentation.
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Figure 4-1   A snapshot of the Tranche core servers. The Google map widget 
was used to show the following snapshot of the core Tranche servers. These are 
servers dedicated to sharing data on the Tranche network.
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Figure 4-2   Snapshot of file types in Tranche. Files in Tranche listed by size with 
information about the number of files. Files with .dat are primarily from 
Water's .raw directory structures, and .tgz are primarily the results of Sequest 
searches.
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Figure 5-1 – Overview of the data upload process in Tranche. Tranche 
automatically handles compression, encryption, splitting of files, and 
replicating data on multiple servers.
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Figure 5-2 – Illustration of a Tranche hash span. Content is evenly 
spread across servers in the Tranche network by pre-configured “hash 
spans”. This ensures that at least a certain number of servers, 
normally 3, get a copy of each bit of data.
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Figure 5-3 – Structure of a Tranche Hash. Tranche uses existing 
hashing algorithms to create a secure and unique identifier for data 
sets. The scheme is a combination of the MD5, SHA-1, and SHA-256 
hashes plus the length of the file.
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Figure 6-1 – Distribution of bonanza scores. Distributions of Bonanza 
scores for the all peak lists compared against all other peak lists for the 
Aurum and Yocum data sets, respectively. The ratio of the 1st best 
cluster score compared to the aggregate cluster score distribution is 
used for approximating valid peak list clusterings. Lower ranked cluster 
scores (10th, 20th, 50th, 100th) quickly converge to a presumed 
distribution of invalid clusterings.
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Figure 6-2 – Histogram of m/z precursor differences in Bonanza 
clustered peak listsHistogram of m/z difference between clustered 
peak lists. Only clusterings where the bonanza score is above threshold 
are plotted, and the +/-6 Da range is omitted. In both plots 0 Da is the 
highest bin (see appendix A for complete plots). Significant trends can 
be observed, which support the proposed use of Bonanza for 
identifying unexpected modifications.
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Figure 6-3 – Example of observed methionine side-chain loss in MS. 
Examination of the Aurum MS data helps explain an unusual neutral 
loss. In light gray is the actual MS spectra. The black lines are the 
called peaks from the peak list. The masses 1,189.7, 1,835.7, and 
1,851.7 are the respective unmodified, oxidized and doubly oxidized 
peptides. If any form of the peptide has a neutral loss of the side-chain 
a peak appears at a net nominal loss of -48 Da from the unmodified 
peptide.
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Figure 6-4 – Select modifications identified by Bonanza and confirmed 
by MS/MS peak lists. (A) and (B) are peak lists clustered together. The 
decoy database search identified the unmodified peak list (A) to be 
QVAEQFLNMR and Bonanza inferred (B) with the neutral loss of the 
methionine side chain. (C) and (D) are another set of peak lists 
clustered together. The decoy database analysis identified (C) as 
YPHCAVNGLLVAEK with a carbamidomethylated cysteine. Bonanza 





Aurum Dataset Yocum Dataset
Starting Peak Lists 9,987 41,942
Filtered Peak Lists (>10 peaks) 9,350 37,772
Peak Lists w/o Clustering 3,998 13,727
Unidentified Clusters 2,274 14,023
Decoy Analysis Peptide Identifications 2,594 6,372
Bonanza Inferred Peak Lists 484 3,650
Table 6-1 – Overview of peak lists and clustering identifications during 
Bonanza analysis for the Aurum and Yocum data set. The Yocum data 
set represents several MudPIT experiments, and is much more 
representative of a shotgun proteomics experiment compared to the 
purified proteins used in Aurum.
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Bonanza (m/z); count Yocum (m/z); count
1 C(57); 760 K(144); 4,607
2 M(16); 342 Y(144); 1,345
3 W(16); 82 C(46); 731
4 C(71); 56 N-term (144); many*
5 H(16); 45 M(16); 148
Table 6-2 – Summary of the top 5 modifications based on identified 
and bonanza-inferred peptide identifications. Two interesting 
observations. First, the Aurum data set appears to have many more 
oxidation events, especially considering it has 1/4th the amount of total 
peak lists. Second, modifications in the Yocum data set confirm obvious 
trends observed in Figure 6-2, and modifications in the Aurum data set 
confirms not so easily explained trends (+/-14 Da is due to 
propionamide) in respective plots in Figure 6-2.
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